<!DOCTYPE html>
<html lang="en" class="no-js">
    <head>
        <title>Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias | BMC Cancer | Full Text</title>

        
    
        
    


        
        
    
    <meta name="journal_id" content='12885'/>
    
    <meta name="dc.title" content='Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias'/>
    
    <meta name="dc.description" content='Gene mutation is an important mechanism of myeloid leukemogenesis. However, the number and combination of gene mutated in myeloid malignancies is still a matter of investigation. We searched for mutations in the ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in 65 myelodysplastic syndromes (MDSs) and 64 acute myeloid leukemias (AMLs) without balanced translocation or complex karyotype. Mutations in ASXL1 and CBL were frequent in refractory anemia with excess of blasts. Mutations in TET2 occurred with similar frequency in MDSs and AMLs and associated equally with either ASXL1 or NPM1 mutations. Mutations of RUNX1 were mutually exclusive with TET2 and combined with ASXL1 but not with NPM1. Mutations in FLT3 (mutation and internal tandem duplication), IDH1, IDH2, NPM1 and WT1 occurred primarily in AMLs. Only 14% MDSs but half AMLs had at least two mutations in the genes studied. Based on the observed combinations and exclusions we classified the 12 genes into four classes and propose a highly speculative model that at least a mutation in one of each class is necessary for developing AML with simple or normal karyotype.'/>
    
    <meta name="dc.source" content='BMC Cancer 2010 10:1'/>
    
    <meta name="dc.format" content='text/html'/>
    
    <meta name="dc.publisher" content='BioMed Central'/>
    
    <meta name="dc.date" content='2010-08-02'/>
    
    <meta name="dc.type" content='OriginalPaper'/>
    
    <meta name="dc.language" content='En'/>
    
    <meta name="dc.copyright" content='2010 Rocquain et al; licensee BioMed Central Ltd.'/>
    
    <meta name="dc.rights" content='http://creativecommons.org/licenses/by/2.0'/>
    
    <meta name="dc.rightsAgent" content='reprints@biomedcentral.com'/>
    
    <meta name="prism.issn" content='1471-2407'/>
    
    <meta name="prism.publicationName" content='BMC Cancer'/>
    
    <meta name="prism.publicationDate" content='2010-08-02'/>
    
    <meta name="prism.volume" content='10'/>
    
    <meta name="prism.number" content='1'/>
    
    <meta name="prism.section" content='OriginalPaper'/>
    
    <meta name="prism.startingPage" content='401'/>
    
    <meta name="prism.copyright" content='2010 Rocquain et al; licensee BioMed Central Ltd.'/>
    
    <meta name="prism.rightsAgent" content='reprints@biomedcentral.com'/>
    
    <meta name="prism.url" content='https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-401'/>
    
    <meta name="citation_pdf_url" content='https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-10-401?site=bmccancer.biomedcentral.com'/>
    
    <meta name="citation_abstract_html_url" content='https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-401'/>
    
    <meta name="citation_fulltext_html_url" content='https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-401'/>
    
    <meta name="citation_journal_title" content='BMC Cancer'/>
    
    <meta name="citation_publisher" content='BioMed Central'/>
    
    <meta name="citation_issn" content='1471-2407'/>
    
    <meta name="citation_title" content='Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias'/>
    
    <meta name="citation_volume" content='10'/>
    
    <meta name="citation_issue" content='1'/>
    
    <meta name="citation_date" content='2010/08/02'/>
    
    <meta name="citation_publication_date" content='2010/08/02'/>
    
    <meta name="citation_firstpage" content='401'/>
    
    <meta name="citation_article_type" content='Research article'/>
    
    <meta name="citation_fulltext_world_readable" content=''/>
    
    <meta name="dc.creator" content='Julien Rocquain'/>
    
    <meta name="dc.creator" content='Nadine Carbuccia'/>
    
    <meta name="dc.creator" content='Virginie Trouplin'/>
    
    <meta name="dc.creator" content='St&#233;phane Raynaud'/>
    
    <meta name="dc.creator" content='Anne Murati'/>
    
    <meta name="dc.creator" content='Meyer Nezri'/>
    
    <meta name="dc.creator" content='Zoulika Tadrist'/>
    
    <meta name="dc.creator" content='Sylviane Olschwang'/>
    
    <meta name="dc.creator" content='Norbert Vey'/>
    
    <meta name="dc.creator" content='Daniel Birnbaum'/>
    
    <meta name="dc.creator" content='V&#233;ronique Gelsi-Boyer'/>
    
    <meta name="dc.creator" content='Marie-Joelle Mozziconacci'/>
    
    <meta name="dc.subject" content='Cancer Research'/>
    
    <meta name="dc.subject" content='Oncology'/>
    
    <meta name="dc.subject" content='Surgical Oncology'/>
    
    <meta name="dc.subject" content='Health Promotion and Disease Prevention'/>
    
    <meta name="dc.subject" content='Biomedicine general'/>
    
    <meta name="dc.subject" content='Medicine/Public Health, general'/>
    
    <meta name="citation_author" content='Julien Rocquain'/>
    
    <meta name="citation_author_institution" content='Centre de Recherche en Canc&#233;rologie de Marseille, Laboratoire d&#39;Oncologie Mol&#233;culaire; UMR891 Inserm; Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author" content='Nadine Carbuccia'/>
    
    <meta name="citation_author_institution" content='Centre de Recherche en Canc&#233;rologie de Marseille, Laboratoire d&#39;Oncologie Mol&#233;culaire; UMR891 Inserm; Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author" content='Virginie Trouplin'/>
    
    <meta name="citation_author_institution" content='Centre de Recherche en Canc&#233;rologie de Marseille, Laboratoire d&#39;Oncologie Mol&#233;culaire; UMR891 Inserm; Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author" content='St&#233;phane Raynaud'/>
    
    <meta name="citation_author_institution" content='Centre de Recherche en Canc&#233;rologie de Marseille, Laboratoire d&#39;Oncologie Mol&#233;culaire; UMR891 Inserm; Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author" content='Anne Murati'/>
    
    <meta name="citation_author_institution" content='Centre de Recherche en Canc&#233;rologie de Marseille, Laboratoire d&#39;Oncologie Mol&#233;culaire; UMR891 Inserm; Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author_institution" content='D&#233;partement de BioPathologie, Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author" content='Meyer Nezri'/>
    
    <meta name="citation_author_institution" content='Service de M&#233;decine Interne, Centre Hospitalier G&#233;n&#233;ral, Martigues, France'/>
    
    <meta name="citation_author" content='Zoulika Tadrist'/>
    
    <meta name="citation_author_institution" content='Service de M&#233;decine Interne-Oncologie, H&#244;pital de Salon-de-Provence, Salon-de-Provence, France'/>
    
    <meta name="citation_author" content='Sylviane Olschwang'/>
    
    <meta name="citation_author_institution" content='Centre de Recherche en Canc&#233;rologie de Marseille, Laboratoire d&#39;Oncologie Mol&#233;culaire; UMR891 Inserm; Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author_institution" content='D&#233;partement de BioPathologie, Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author" content='Norbert Vey'/>
    
    <meta name="citation_author_institution" content='Facult&#233; de M&#233;decine, Universit&#233; de la M&#233;diterran&#233;e, Marseille, France'/>
    
    <meta name="citation_author_institution" content='D&#233;partement d&#39;H&#233;matologie, Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author" content='Daniel Birnbaum'/>
    
    <meta name="citation_author_institution" content='Centre de Recherche en Canc&#233;rologie de Marseille, Laboratoire d&#39;Oncologie Mol&#233;culaire; UMR891 Inserm; Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author" content='V&#233;ronique Gelsi-Boyer'/>
    
    <meta name="citation_author_institution" content='Centre de Recherche en Canc&#233;rologie de Marseille, Laboratoire d&#39;Oncologie Mol&#233;culaire; UMR891 Inserm; Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author_institution" content='D&#233;partement de BioPathologie, Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author_institution" content='Facult&#233; de M&#233;decine, Universit&#233; de la M&#233;diterran&#233;e, Marseille, France'/>
    
    <meta name="citation_author" content='Marie-Joelle Mozziconacci'/>
    
    <meta name="citation_author_institution" content='Centre de Recherche en Canc&#233;rologie de Marseille, Laboratoire d&#39;Oncologie Mol&#233;culaire; UMR891 Inserm; Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_author_institution" content='D&#233;partement de BioPathologie, Institut Paoli-Calmettes, Marseille, France'/>
    
    <meta name="citation_reference" content='citation_journal_title=N Eng J Med; citation_title=Myelodysplastic syndromes; citation_author=A Tefferi; citation_author=JW Vardiman; citation_volume=361; citation_publication_date=2009; citation_pages=1872-1885; citation_doi=10.1056/NEJMra0902908; citation_id=CR1;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Leukemia; citation_title=Myelodysplastic syndromes: lost between two states?; citation_author=C Acquaviva; citation_author=V Gelsi-Boyer; citation_author=D Birnbaum; citation_volume=24; citation_publication_date=2010; citation_pages=1-5; citation_doi=10.1038/leu.2009.157; citation_id=CR2;'/>
    
    <meta name="citation_reference" content='citation_journal_title=N Engl J Med; citation_title=Mutation in TET2in myeloid cancers; citation_author=F Delhommeau; citation_author=S Dupont; citation_author=V Della Valle; citation_author=C James; citation_author=S Trannoy; citation_author=A Mass&#233;; citation_author=O Kosmider; citation_author=JP Le Couedic; citation_author=F Robert; citation_author=A Alberdi; citation_author=I Plo; citation_author=FJ Dreyfus; citation_author=C Marzac; citation_author=N Casadevall; citation_author=C Lacombe; citation_author=SP Romana; citation_author=P Dessen; citation_author=J Soulier; citation_author=F Vigui&#233;; citation_author=M Fontenay; citation_author=W Vainchenker; citation_author=OA Bernard; citation_volume=360; citation_publication_date=2009; citation_pages=2289-2301; citation_doi=10.1056/NEJMoa0810069; citation_id=CR3;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Leukemia; citation_title=Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML; citation_author=A Tefferi; citation_author=KH Lim; citation_author=O Abdel-Wahab; citation_author=TL Lasho; citation_author=J Patel; citation_author=MM Patnaik; citation_author=CA Hanson; citation_author=A Pardanani; citation_author=DG Gilliland; citation_author=RL Levine; citation_volume=23; citation_publication_date=2009; citation_pages=1343-1345; citation_doi=10.1038/leu.2009.59; citation_id=CR4;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Blood; citation_title=Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms; citation_author=AM Jankowska; citation_author=H Szpurka; citation_author=RV Tiu; citation_author=H Makishima; citation_author=M Afable; citation_author=J Huh; citation_author=CL O&#39;Keefe; citation_author=R Ganetzky; citation_author=MA McDevitt; citation_author=JP Maciejewski; citation_volume=113; citation_publication_date=2009; citation_pages=6403-6410; citation_doi=10.1182/blood-2009-02-205690; citation_id=CR5;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Blood; citation_title=Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies; citation_author=O Abdel-Wahab; citation_author=A Mullally; citation_author=C Hedvat; citation_author=G Garcia-Manero; citation_author=J Patel; citation_author=M Wadleigh; citation_author=S Malinge; citation_author=JJ Yao; citation_author=O Kilpivaara; citation_author=R Bhat; citation_author=K Huberman; citation_author=S Thomas; citation_author=I Dolgalev; citation_author=A Heguy; citation_author=E Paietta; citation_author=MM Le Beau; citation_author=M Beran; citation_author=MS Tallman; citation_author=BL Ebert; citation_author=HM Kantarjian; citation_author=RM Stone; citation_author=DG Gilliland; citation_author=JD Crispino; citation_author=RL Levine; citation_volume=114; citation_publication_date=2009; citation_pages=144-147; citation_doi=10.1182/blood-2009-03-210039; citation_id=CR6;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Nat Genet; citation_title=Acquired mutations in TET2 are common in myelodysplastic syndromes; citation_author=SM Langemeijer; citation_author=RP Kuiper; citation_author=M Berends; citation_author=R Knops; citation_author=MG Aslanyan; citation_author=M Massop; citation_author=E Stevens-Linders; citation_author=P van Hoogen; citation_author=A Geurts van Kessel; citation_author=RAP Raymakers; citation_author=EJ Kamping; citation_author=GE Verhoef; citation_author=E Verburgh; citation_author=A Hagemeijer; citation_author=P Vandenberghe; citation_author=T de Witte; citation_author=BA van der Reijden; citation_author=JH Janssen; citation_volume=41; citation_publication_date=2009; citation_pages=838-842; citation_doi=10.1038/ng.391; citation_id=CR7;'/>
    
    <meta name="citation_reference" content='citation_journal_title=J Clin Oncol; citation_title=Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromes; citation_author=AM Mohamedali; citation_author=AE Smith; citation_author=J Gaken; citation_author=NC Lea; citation_author=SA Mian; citation_author=NB Westwood; citation_author=C Strupp; citation_author=N Gattermann; citation_author=U Germing; citation_author=GJ Mufti; citation_volume=27; citation_publication_date=2009; citation_pages=4002-4006; citation_doi=10.1200/JCO.2009.22.6985; citation_id=CR8;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Blood; citation_title=TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDS); citation_author=O Kosmider; citation_author=V Gelsi-Boyer; citation_author=M Cheok; citation_author=S Grabar; citation_author=V Della-Valle; citation_author=F Picard; citation_author=F Vigui&#233;; citation_author=B Quesnel; citation_author=O Beyne-Rauzy; citation_author=E Solary; citation_author=N Vey; citation_author=M Hunault-Berger; citation_author=P Fenaux; citation_author=V Mansat-De Mas; citation_author=E Delabesse; citation_author=P Guardiola; citation_author=C Lacombe; citation_author=W Vainchenker; citation_author=C Preudhomme; citation_author=F Dreyfus; citation_author=OA Bernard; citation_author=D Birnbaum; citation_author=M Fontenay; citation_volume=114; citation_publication_date=2009; citation_pages=3285-3291; citation_doi=10.1182/blood-2009-04-215814; citation_id=CR9;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Br J Haematol; citation_title=Mutations of polycomb-associated gene ASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia; citation_author=V Gelsi-Boyer; citation_author=V Trouplin; citation_author=J Ad&#233;la&#239;de; citation_author=J Bonansea; citation_author=N Cervera; citation_author=N Carbuccia; citation_author=A Lagarde; citation_author=T Pr&#233;bet; citation_author=M Nezri; citation_author=D Sainty; citation_author=S Olschwang; citation_author=L Xerri; citation_author=M Chaffanet; citation_author=MJ Mozziconacci; citation_author=N Vey; citation_author=D Birnbaum; citation_volume=145; citation_publication_date=2009; citation_pages=788-800; citation_doi=10.1111/j.1365-2141.2009.07697.x; citation_id=CR10;'/>
    
    <meta name="citation_reference" content='citation_journal_title=J Clin Oncol; citation_title=Mutations of E3 ligase Cblfamily members constitute a novel common pathogenic lesion in myeloid malignancies; citation_author=H Makishima; citation_author=H Cazzolli; citation_author=H Szpurka; citation_author=A Dunbar; citation_author=R Tiu; citation_author=J Huh; citation_author=H Muramatsu; citation_author=C O&#39;Keefe; citation_author=E Hsi; citation_author=RL Paquette; citation_author=S Kojima; citation_author=AF List; citation_author=MA Sekeres; citation_author=MA McDevitt; citation_author=JP Maciejewski; citation_volume=27; citation_publication_date=2009; citation_pages=6109-6116; citation_doi=10.1200/JCO.2009.23.7503; citation_id=CR11;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Leukemia; citation_title=Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications; citation_author=B Falini; citation_author=N Bolli; citation_author=A Liso; citation_author=MP Martelli; citation_author=R Mannucci; citation_author=S Pileri; citation_author=N Nicoletti; citation_volume=23; citation_publication_date=2009; citation_pages=1731-1743; citation_doi=10.1038/leu.2009.124; citation_id=CR12;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Semin Oncol; citation_title=Prognostic implications of gene mutations in acute myeloid leukemia with normal karyotype; citation_author=V Gaidzik; citation_author=K D&#246;hner; citation_volume=35; citation_publication_date=2008; citation_pages=346-355; citation_doi=10.1053/j.seminoncol.2008.04.005; citation_id=CR13;'/>
    
    <meta name="citation_reference" content='citation_journal_title=N Eng J Med; citation_title=Recurrent mutations found by sequencing an acute myeloid leukemia genome; citation_author=ER Mardis; citation_author=L Ding; citation_author=DJ Dooling; citation_author=DE Larson; citation_author=MD McLellan; citation_author=K Chen; citation_author=DC Koboldt; citation_author=RS Fulton; citation_author=KD Delehaunty; citation_author=SD McGrath; citation_author=LA Fulton; citation_author=DP Locke; citation_author=VJ Magrini; citation_author=RM Abbott; citation_author=TL Vickery; citation_author=JS Reed; citation_author=JS Robinson; citation_author=T Wylie; citation_author=SM Smith; citation_author=L Carmichael; citation_author=JM Elred; citation_author=CC Harris; citation_author=J Walker; citation_author=JB Peck; citation_author=F Du; citation_author=AF Dukes; citation_author=GE Sanderson; citation_author=AM Brummett; citation_author=E Clark; citation_author=JF McMichael; citation_author=RJ Meyer; citation_author=JK Schindler; citation_author=CS Pohl; citation_author=JW Wallis; citation_author=X Shi; citation_author=L Lin; citation_author=H Schmidt; citation_author=Y Tang; citation_author=C Haipek; citation_author=ME Wiechert; citation_author=JV Ivy; citation_author=J Kalicki; citation_author=G Elliott; citation_author=RE Ries; citation_author=JE Payton; citation_author=P Westervelt; citation_author=MH Tomasson; citation_author=MA Watson; citation_author=J Baty; citation_author=S Heath; citation_author=WD Shannon; citation_author=R Nagarajan; citation_author=DC Link; citation_author=MJ Walter; citation_author=TA Graubert; citation_author=JF DiPersio; citation_author=RK Wilson; citation_author=TJ Ley; citation_volume=361; citation_publication_date=2009; citation_pages=1058-1066; citation_doi=10.1056/NEJMoa0903840; citation_id=CR14;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Leukemia; citation_title=Mutual exclusion of ASXL1 and NPM1mutations in a series of acute myeloid leukemias; citation_author=N Carbuccia; citation_author=V Trouplin; citation_author=V Gelsi-Boyer; citation_author=A Murati; citation_author=J Rocquain; citation_author=J Ad&#233;la&#239;de; citation_author=S Olschwang; citation_author=L Xerri; citation_author=N Vey; citation_author=M Chaffanet; citation_author=D Birnbaum; citation_author=MJ Mozziconacci; citation_volume=24; citation_publication_date=2010; citation_pages=469-473; citation_doi=10.1038/leu.2009.218; citation_id=CR15;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Semin Hematol; citation_title=Molecular genetics of human leukemias: new insights into therapy; citation_author=DG Gilliland; citation_volume=39; citation_publication_date=2002; citation_pages=6-11; citation_doi=10.1053/shem.2002.36921; citation_id=CR16;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Blood; citation_title=The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes; citation_author=JW Vardiman; citation_author=J Thiele; citation_author=DA Arber; citation_author=RD Brunning; citation_author=MJ Borowitz; citation_author=A Porwit; citation_author=NL Harris; citation_author=MM Le Beau; citation_author=E Hellstr&#246;m-Lindberg; citation_author=A Tefferi; citation_author=CD Bloomfield; citation_volume=114; citation_publication_date=2009; citation_pages=937-951; citation_doi=10.1182/blood-2009-03-209262; citation_id=CR17;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Leukemia; citation_title=Genomic profiling of acute myelomonocytic leukemia: alteration of the MYB locusin MYST3-linked cases; citation_author=A Murati; citation_author=C Gervais; citation_author=N Carbuccia; citation_author=P Finetti; citation_author=N Cervera; citation_author=J Ad&#233;la&#239;de; citation_author=S Struski; citation_author=E Lippert; citation_author=F Mugneret; citation_author=I Tigaud; citation_author=D Penther; citation_author=C Bastard; citation_author=B Poppe; citation_author=F Speleman; citation_author=L Baranger; citation_author=I Luquet; citation_author=P Cornillet-Lefebvre; citation_author=N Nadal; citation_author=F Nguyen-Khac; citation_author=C P&#233;rot; citation_author=S Olschwang; citation_author=F Bertucci; citation_author=M Chaffanet; citation_author=M Lessard; citation_author=MJ Mozziconacci; citation_author=D Birnbaum; citation_volume=23; citation_publication_date=2009; citation_pages=85-94; citation_doi=10.1038/leu.2008.257; citation_id=CR18;'/>
    
    <meta name="citation_reference" content='citation_journal_title=BMC Cancer; citation_title=Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1genes; citation_author=V Gelsi-Boyer; citation_author=V Trouplin; citation_author=J Ad&#233;la&#239;de; citation_author=N Aceto; citation_author=V Remy; citation_author=S Pinson; citation_author=C Houdayer; citation_author=C Arnoulet; citation_author=D Sainty; citation_author=M Bentires-Alj; citation_author=S Olschwang; citation_author=N Vey; citation_author=MJ Mozziconacci; citation_author=D Birnbaum; citation_author=M Chaffanet; citation_volume=8; citation_publication_date=2008; citation_pages=299-314; citation_doi=10.1186/1471-2407-8-299; citation_id=CR19;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Nature; citation_title=Gain-of-function of mutated CBL tumour suppressor in myeloid neoplasms; citation_author=M Sanada; citation_author=T Suzuki; citation_author=LY Shih; citation_author=M Otsu; citation_author=M Kato; citation_author=S Yamasaki; citation_author=A Tamura; citation_author=H Honda; citation_author=M Sakata-Yanagimoto; citation_author=K Kumano; citation_author=H Oda; citation_author=T Yamagata; citation_author=J Takita; citation_author=N Gotoh; citation_author=K Nakazaki; citation_author=N Kawamata; citation_author=M Onodera; citation_author=M Nobuyoshi; citation_author=Y Hayashi; citation_author=H Harada; citation_author=M Kurokawa; citation_author=S Chiba; citation_author=H Mori; citation_author=K Ozawa; citation_author=M Omine; citation_author=H Hirai; citation_author=H Nakauchi; citation_author=HP Koeffler; citation_author=S Ogawa; citation_volume=460; citation_publication_date=2009; citation_pages=904-908; citation_doi=10.1038/nature08240; citation_id=CR20;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Cancer; citation_title=Wilms tumor gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association; citation_author=A Renneville; citation_author=N Boissel; citation_author=V Zurawski; citation_author=L Llopis; citation_author=V Biggio; citation_author=O Nibourel; citation_author=N Philippe; citation_author=X Thomas; citation_author=H Dombret; citation_author=C Preudhomme; citation_volume=115; citation_publication_date=2009; citation_pages=3719-3727; citation_doi=10.1002/cncr.24442; citation_id=CR21;'/>
    
    <meta name="citation_reference" content='citation_journal_title=J Clin Oncol; citation_title=Mutation of the Wilm&#39;s tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukaemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party; citation_author=P Virappane; citation_author=R Gale; citation_author=R Hills; citation_author=I Kakkas; citation_author=K Summers; citation_author=J Stevens; citation_author=C Allen; citation_author=C Green; citation_author=H Quentmeier; citation_author=H Drexler; citation_author=A Burnett; citation_author=D Linch; citation_author=D Bonnet; citation_author=TA Lister; citation_author=J Fitzgibbon; citation_volume=26; citation_publication_date=2008; citation_pages=5429-5435; citation_doi=10.1200/JCO.2008.16.0333; citation_id=CR22;'/>
    
    <meta name="citation_reference" content='citation_journal_title=New Engl J Med; citation_title=Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms; citation_author=A Green; citation_author=P Beer; citation_volume=362; citation_publication_date=2010; citation_pages=369-370; citation_doi=10.1056/NEJMc0910063; citation_id=CR23;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Cancer Cell; citation_title=The common features of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting &#945;-ketoglutarate to 2-hydoxyglutarate; citation_author=PS Ward; citation_author=J Patel; citation_author=DR Wise; citation_author=O Abdel-Wahab; citation_author=B Bennett; citation_author=HA Coller; citation_author=JR Cross; citation_author=VR Fantin; citation_author=CV Hedvat; citation_author=AE Perl; citation_author=JD Rabinowitz; citation_author=M Carroll; citation_author=S Su; citation_author=KA Sharp; citation_author=RL Levine; citation_author=CB Thompson; citation_volume=17; citation_publication_date=2010; citation_pages=1-10; citation_doi=10.1016/j.ccr.2010.01.020; citation_id=CR24;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Leukemia; citation_title=Frequent mutations of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia; citation_author=J Boultwood; citation_author=J Perry; citation_author=A Pellagatti; citation_author=M Fernandez-Mercado; citation_author=C Fernandez-Santamaria; citation_author=MJ Calasanz; citation_author=MJ Larrayoz; citation_author=M Garcia-Delgado; citation_author=A Giagounidis; citation_author=L Malcovati; citation_author=MG Della Porta; citation_author=M J&#228;dersten; citation_author=S Killick; citation_author=E Hellstr&#246;m-Lindbergh; citation_author=M Cazzola; citation_author=JS Wainscoat; citation_volume=24; citation_publication_date=2010; citation_pages=1062-1065; citation_doi=10.1038/leu.2010.20; citation_id=CR25;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Leukemia; citation_title=FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates; citation_author=C Lavagna-S&#233;venier; citation_author=S Marchetto; citation_author=D Birnbaum; citation_author=O Rosnet; citation_volume=12; citation_publication_date=1998; citation_pages=301-310; citation_doi=10.1038/sj.leu.2400921; citation_id=CR26;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Cancer Res; citation_title=250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies; citation_author=AJ Dunbar; citation_author=LP Gondek; citation_author=CL O&#39;Keefe; citation_author=H Makishima; citation_author=MS Rataul; citation_author=H Szpurka; citation_author=MA Sekeres; citation_author=XF Wang; citation_author=MA McDevitt; citation_author=JP Maciejewski; citation_volume=68; citation_publication_date=2008; citation_pages=10340-10357; citation_doi=10.1158/0008-5472.CAN-08-2754; citation_id=CR27;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Science; citation_title=Puzzling patterns of predisposition; citation_author=PJ Pollard; citation_author=PJ Ratcliffe; citation_volume=324; citation_publication_date=2009; citation_pages=192-194; citation_doi=10.1126/science.1173362; citation_id=CR28;'/>
    
    <meta name="citation_reference" content='citation_journal_title=FASEB J; citation_title=Oxygen-regulated expression of the Wilm&#39;s tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1); citation_author=KD Wagner; citation_author=N Wagner; citation_author=S Wellman; citation_author=G Schley; citation_author=A Bondke; citation_author=H Theres; citation_author=H Scholz; citation_volume=17; citation_publication_date=2003; citation_pages=1364-1366; citation_id=CR29;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Leukemia; citation_title=Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias; citation_author=L Couronn&#233;; citation_author=E Lippert; citation_author=J Andrieux; citation_author=O Kosmider; citation_author=I Radford-Weiss; citation_author=D Penther; citation_volume=24; citation_publication_date=2010; citation_pages=201-203; citation_doi=10.1038/leu.2009.169; citation_id=CR30;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Leukemia; citation_title=Alterations of NFIAin chronic malignant myeloid diseases; citation_author=F Bernard; citation_author=V Gelsi-Boyer; citation_author=A Murati; citation_author=S Giraudier; citation_author=V Trouplin; citation_author=J Ad&#233;la&#239;de; citation_author=J Rey; citation_author=S Olschwang; citation_author=W Vainchenker; citation_author=M Chaffanet; citation_author=N Vey; citation_author=MJ Mozziconacci; citation_author=D Birnbaum; citation_volume=23; citation_publication_date=2009; citation_pages=583-585; citation_doi=10.1038/leu.2008.228; citation_id=CR31;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Nat Genet; citation_title=Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer; citation_author=G van Haaften; citation_author=GL Dalgliesh; citation_author=H Davies; citation_author=L Chen; citation_author=G Bignell; citation_author=C Greenman; citation_author=S Edkins; citation_author=C Hardy; citation_author=S O&#39;Meara; citation_author=J Teague; citation_author=A Butler; citation_author=J Hinton; citation_author=C Latimer; citation_author=J Andrews; citation_author=S Barthorpe; citation_author=D Beare; citation_author=G Buck; citation_author=PJ Campbell; citation_author=J Cole; citation_author=S Forbes; citation_author=M Jia; citation_author=D Jones; citation_author=CY Kok; citation_author=C Leroy; citation_author=ML Lin; citation_author=DJ McBride; citation_author=M Maddison; citation_author=S Maquire; citation_author=K McLay; citation_author=A Menzies; citation_author=T Mironenko; citation_author=L Mulderrig; citation_author=L Mudie; citation_author=E Pleasance; citation_author=R Shepherd; citation_author=R Smith; citation_author=L Stebbings; citation_author=P Stephens; citation_author=G Tang; citation_author=PS Tarpey; citation_author=R Turner; citation_author=K Turrell; citation_author=J Varian; citation_author=S West; citation_author=S Widaa; citation_author=P Wray; citation_author=VP Collins; citation_author=K Ichimura; citation_author=S Law; citation_author=J Wong; citation_author=ST Yuen; citation_author=SY Leung; citation_author=G Tonon; citation_author=RA DePinho; citation_author=YT Tai; citation_author=KC Anderson; citation_author=RJ Kahnoski; citation_author=A Massie; citation_author=SK Khoo; citation_author=BT Teh; citation_author=MR Stratton; citation_author=PA Futreal; citation_volume=41; citation_publication_date=2009; citation_pages=521-523; citation_doi=10.1038/ng.349; citation_id=CR32;'/>
    
    <meta name="citation_reference" content='citation_title=Inactivating mutations of the histone methyltransferase gene EZH2in myeloid disorders; citation_inbook_title=Nat Genet; citation_author=T Ernst; citation_author=AJ Chase; citation_author=J Score; citation_author=CE Hidalgo-Curtis; citation_author=C Bryant; citation_author=AV Jones; citation_author=K Waghorn; citation_author=K Zoi; citation_author=FM Ross; citation_author=A Reiter; citation_author=A Hochhaus; citation_author=HG Drexler; citation_author=A Duncombe; citation_author=F Cervantes; citation_author=D Oscier; citation_author=J Boultwood; citation_author=FH Grand; citation_author=NCP Cross; citation_publication_date=2010; citation_id=CR33;'/>
    
    <meta name="citation_reference" content='citation_title=Somatic mutations of the histone methyltransferase gene EZH2in myelodysplastic syndromes; citation_inbook_title=Nat Genet; citation_author=G Nikoloski; citation_author=SMC Langemeijer; citation_author=RP Kuiper; citation_author=R Knops; citation_author=M Massop; citation_author=ERLTM T&#246;nnissen; citation_author=A van der Heijden; citation_author=TN Scheele; citation_author=P Vandenberghe; citation_author=T de Witte; citation_author=BA van der Reijden; citation_author=JH Jansen; citation_publication_date=2010; citation_id=CR34;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Blood; citation_title=AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms; citation_author=Y Ding; citation_author=Y Harada; citation_author=J Imagawa; citation_author=A Kimura; citation_author=H Harada; citation_volume=114; citation_publication_date=2009; citation_pages=5201-5205; citation_doi=10.1182/blood-2009-06-223982; citation_id=CR35;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Cancer Res; citation_title=Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias; citation_author=O Abdel-Wahab; citation_author=T Mansouri; citation_author=J Patel; citation_author=K Harris; citation_author=J Yao; citation_author=C Hedvat; citation_author=C Hedvat; citation_author=A Heguy; citation_author=C Bueso-Ramos; citation_author=H Kantarjian; citation_author=RL Levine; citation_author=S Verstovsek; citation_volume=70; citation_publication_date=2010; citation_pages=447-452; citation_doi=10.1158/0008-5472.CAN-09-3783; citation_id=CR36;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Nature; citation_title=Cancer-associated IDH1 mutations produce 2-hydroxyglutarate; citation_author=L Dang; citation_author=DW White; citation_author=S Gross; citation_author=BD Bennett; citation_author=MAA Bittinger; citation_author=EM Driggers; citation_author=VR Fantin; citation_author=HG Jang; citation_author=S Jin; citation_author=MC Keenan; citation_author=KM Marks; citation_author=RM Prins; citation_author=PS Ward; citation_author=KE Yen; citation_author=LM Liau; citation_author=JD Rabinowitz; citation_author=LC Cantley; citation_author=CB Thompson; citation_author=MG Vander Heiden; citation_author=SM Su; citation_volume=462; citation_publication_date=2009; citation_pages=739-744; citation_doi=10.1038/nature08617; citation_id=CR37;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Nat Rev Cancer; citation_title=Nucleophosmin and cancer; citation_author=S Grisendi; citation_author=C Mecucci; citation_author=B Falini; citation_author=PP Pandolfi; citation_volume=494; citation_publication_date=2006; citation_pages=493-505; citation_doi=10.1038/nrc1885; citation_id=CR38;'/>
    
    <meta name="citation_reference" content='citation_journal_title=Blood; citation_title=Loss-of-function Additional sex coombs-like 1mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia; citation_author=CL Fisher; citation_author=N Pineault; citation_author=C Brookes; citation_author=CD Helgason; citation_author=H Ohta; citation_author=C Bodner; citation_author=JL Hess; citation_author=RK Humphries; citation_author=HW Brock; citation_volume=115; citation_publication_date=2010; citation_pages=38-46; citation_doi=10.1182/blood-2009-07-230698; citation_id=CR39;'/>
    
    <meta name="prism.doi" content='10.1186/1471-2407-10-401'/>
    
    <meta name="dc.identifier" content='10.1186/1471-2407-10-401'/>
    
    <meta name="citation_doi" content='10.1186/1471-2407-10-401'/>
    
    <meta name="citation_abstract" content='&lt;h2&gt;Abstract&lt;/h2&gt; &lt;h3&gt;Background&lt;/h3&gt; Gene mutation is an important mechanism of myeloid leukemogenesis. However, the number and combination of gene mutated in myeloid malignancies is still a matter of investigation.  &lt;h3&gt;Methods&lt;/h3&gt; We searched for mutations in the &lt;i&gt;ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2&lt;/i&gt; and &lt;i&gt;WT1&lt;/i&gt; genes in 65 myelodysplastic syndromes (MDSs) and 64 acute myeloid leukemias (AMLs) without balanced translocation or complex karyotype.  &lt;h3&gt;Results&lt;/h3&gt; Mutations in &lt;i&gt;ASXL1&lt;/i&gt; and &lt;i&gt;CBL&lt;/i&gt; were frequent in refractory anemia with excess of blasts. Mutations in &lt;i&gt;TET2&lt;/i&gt; occurred with similar frequency in MDSs and AMLs and associated equally with either &lt;i&gt;ASXL1&lt;/i&gt; or &lt;i&gt;NPM1&lt;/i&gt; mutations. Mutations of &lt;i&gt;RUNX1&lt;/i&gt; were mutually exclusive with &lt;i&gt;TET2&lt;/i&gt; and combined with &lt;i&gt;ASXL1&lt;/i&gt; but not with &lt;i&gt;NPM1&lt;/i&gt;. Mutations in &lt;i&gt;FLT3 (&lt;/i&gt;mutation and internal tandem duplication), &lt;i&gt;IDH1&lt;/i&gt;, &lt;i&gt;IDH2&lt;/i&gt;, &lt;i&gt;NPM1&lt;/i&gt; and &lt;i&gt;WT1&lt;/i&gt; occurred primarily in AMLs.  &lt;h3&gt;Conclusion&lt;/h3&gt; Only 14% MDSs but half AMLs had at least two mutations in the genes studied. Based on the observed combinations and exclusions we classified the 12 genes into four classes and propose a highly speculative model that at least a mutation in one of each class is necessary for developing AML with simple or normal karyotype.'/>
    
    <meta name="DOI" content='10.1186/1471-2407-10-401'/>
    

        
    <script type="text/javascript">
        dataLayer = [{"content":{"article":{"doi":"10.1186/1471-2407-10-401","articleType":"Research article","peerReviewType":"Open"},"contentInfo":{"imprint":"BioMed Central","title":"Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias","publishedAt":1280707200000,"publishedAtDate":"2010-08-02","authors":["Julien Rocquain","Nadine Carbuccia","Virginie Trouplin","Stéphane Raynaud","Anne Murati","Meyer Nezri","Zoulika Tadrist","Sylviane Olschwang","Norbert Vey","Daniel Birnbaum","Véronique Gelsi-Boyer","Marie-Joelle Mozziconacci"],"collections":[]},"attributes":{"deliveryPlatform":"oscar","template":null,"cms":null,"copyright":{"creativeCommonsType":null}},"journal":{"volume":"10","issue":"1","title":"BMC Cancer","category":"SERIES","id":12885},"category":{"pmc":{"primarySubject":"Biomedicine"}}}}]

    </script>

        

        <meta charset="UTF-8"/>
        <meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <meta name="viewport" content="width=device-width, initial-scale=1"/>
        <!-- For IE 9 and below -->
<!--[if IE]><link rel="shortcut icon" href=/static/images/favicons/biomedcentral/favicon-dc10a51d5f.ico><![endif]-->
<!-- Touch Icons - iOS and Android 2.1+ -->
<link rel="apple-touch-icon" href=/static/images/favicons/biomedcentral/favicon-0969f3a317.png>
<!-- Firefox, Chrome, Safari, IE 11+ and Opera -->
<link rel="icon" href=/static/images/favicons/biomedcentral/favicon-0969f3a317.png>
        <script>(function(H){H.className=H.className.replace(/\bno-js\b/,'js')})(document.documentElement)</script>
        <script>(function(d) {if (sessionStorage.getItem('webfonts') == 'true'){d.className += ' webfonts-loaded';}})(document.documentElement);</script>
        <link rel="stylesheet" media="screen" href=/static/styles/basic/basic-8a9ed7dce9.css>
<link rel="stylesheet" media="print" href=/static/styles/biomedcentral/biomedcentral-print-9d9c0bc8d5.css>

<link rel="stylesheet" class="js-ctm" href=/static/styles/biomedcentral/biomedcentral-1a58e9106c.css
      media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)">
        
    <script type="text/javascript">
        config = {
            env: 'live',
            site: 'bmccancer.biomedcentral.com',
            siteWithPath: 'bmccancer.biomedcentral.com' + window.location.pathname,
            twitterHashtag: '',
            cmsPrefix: 'http://studio-cms.springer.com/studio/',
            
            doi: '10.1186/1471-2407-10-401',
            figshareScriptUrl: 'https://widgets.figshare.com/static/figshare.js',
            publisherBrand: 'BioMed Central'
        };
    </script>

        
    
    <script>
        window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date;

        (function() {
            var sampleRate = 20;

            ga('create', "UA-62067970-3", {
                cookieDomain: 'none',
                allowLinker: true,
                siteSpeedSampleRate: sampleRate
            });

            ga("set", "anonymizeIp", true);
            ga('send', 'pageview');

        
            ga('create', "UA-54492316-9", {
                cookieDomain: 'none',
                allowLinker: true,
                siteSpeedSampleRate: sampleRate,
                name: 'global'
            });
            ga("global.set", "anonymizeIp", true);
            ga('global.send', 'pageview');
            ga('set', 'transport', 'beacon');
        
        }())
    </script>
    <script async src='https://www.google-analytics.com/analytics.js'></script>
    

        
    
    <link rel="canonical" href="//bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-401"/>
    


        

        
        
    <meta property="og:url" content="https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-401"/>
    <meta property="og:type" content="article"/>
    <meta property="og:site_name" content="BMC Cancer"/>
    <meta property="og:title" content="Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias"/>
    <meta property="og:description" content="Gene mutation is an important mechanism of myeloid leukemogenesis. However, the number and combination of gene mutated in myeloid malignancies is still a matter of investigation. We searched for mutations in the ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in 65 myelodysplastic syndromes (MDSs) and 64 acute myeloid leukemias (AMLs) without balanced translocation or complex karyotype. Mutations in ASXL1 and CBL were frequent in refractory anemia with excess of blasts. Mutations in TET2 occurred with similar frequency in MDSs and AMLs and associated equally with either ASXL1 or NPM1 mutations. Mutations of RUNX1 were mutually exclusive with TET2 and combined with ASXL1 but not with NPM1. Mutations in FLT3 (mutation and internal tandem duplication), IDH1, IDH2, NPM1 and WT1 occurred primarily in AMLs. Only 14% MDSs but half AMLs had at least two mutations in the genes studied. Based on the observed combinations and exclusions we classified the 12 genes into four classes and propose a highly speculative model that at least a mutation in one of each class is necessary for developing AML with simple or normal karyotype."/>
    <meta property="og:image" content="https://images.springer.com/sgw/journals/medium/12885.jpg"/>

        
    </head>

    <body class="fulltext" >
    
    
        
    

    
    <div class="container" style="height: 0"><div id="wt_refpoint"></div></div>
    <p class="skip-to-main">
    <a class="skip-to-main__link" href="#main">Skip to main content</a>
</p>

    <div id="top">
        
<div id="RealMediaLeaderboard" class="adsbox RealMediaAd Ad Ad--leaderboard" data-position="Top">
    <div class="Ad_content">
        <p class="Ad_label">Advertisement</p>
        
    </div>
</div>


        



         
    <div id="membership-message-loader-desktop" class="placeholder" data-placeholder="/placeholder/v1/membership/message"></div>
    <header class="header" role="banner">
        <div class="header__inner">
            <a id="header-logo" href="//www.biomedcentral.com/" class="logo header__logo" title="BioMed Central">
                <img srcset="/static/images/biomed-central-logo-976eb64772.svg" src="/static/images/biomed-central-logo-5300b47908.png" class="logo__img" alt="Biomed Central" />
            </a>
            <div class="header__right">
                <div class="toggles js-fade-toggle">
                    <p id="loginLink" class="sign-in toggles__item" data-replace="true" data-placeholder="/placeholder/v1/username">
    <a class="sign-in__link" href="//www.biomedcentral.com/login" data-track-event="click" data-event-category="Account" data-event-action="Click Login Link">
        <span class="sign-in__no-js-account-hide">Login
            <span class="sign-in__js-account-hide"> to </span>
        </span>
        <span class="sign-in__js-account-hide sign-in__no-js-capitalise">your account</span>
    </a>
</p>
                    
                    <a href="#globalSearch" class="toggles__item toggles__item--search" data-toggle="search"><span class="sr-only">Search</span></a>
                </div>
                <form role="search" id="globalSearch" class="search search--expandable header__search" method="GET" action="//www.biomedcentral.com/search" data-track-event="submit"
      data-event-category="Search and Results" data-event-action="Submit search" data-event-label="">
    <div class="search__content">
        <label for="publisherSearch" class="sr-only">Search BioMed Central articles</label>
        <input id="publisherSearch" class="search__input" autocomplete="off" role="textbox" name="query" type="text" value="" title="Search BioMed Central" placeholder="Search BioMed Central articles"/>
        <button id="search" class="search__button" type="submit">
            <span class="sr-only">Search</span>
        </button>
        <input type="hidden" name="searchType" value="publisherSearch"/>
    </div>
</form>

            </div>
            
        </div>
    </header>

        <main role="main">
            
            <header class="journal-header" role="banner">
                <div class="journal-header__inner">
                    <h2 class="journal-header__title journal-header__title--medium" id="journalTitle">
                        
                        <a class="journal-header__title-text" href="/">
                            BMC Cancer
                        </a>
                    </h2>
                    
                </div>
                <div class="navbar">
                    <div class="navbar__inner">
                        

                        
                        <nav class="navbar__nav">
                            <h3 class="navbar__menu-toggle" data-toggle="collapse" data-target="journal-menu">
                                <span class="sr-only">Main </span>menu
                            </h3>
                            <ul id="journal-menu" class="navbar__menu" id="siteNavigation" role="menu">
                                
                                    <li class="navbar__item" role="menuitem">
                                        <a class="navbar__link" href='/'>Home</a>
                                    </li>
                                
                                    <li class="navbar__item" role="menuitem">
                                        <a class="navbar__link" href='/about'>About</a>
                                    </li>
                                
                                    <li class="navbar__item" role="menuitem">
                                        <a class="navbar__link is-active" href='/articles'>Articles</a>
                                    </li>
                                
                                    <li class="navbar__item" role="menuitem">
                                        <a class="navbar__link" href='/submission-guidelines'>Submission Guidelines</a>
                                    </li>
                                
                            </ul>
                        </nav>
                        
                    </div>
                </div>
                <div class="journal-identity journal-identity--networks-aqua">
                    
                </div>
            </header>
            
        
            <div class="container">
                
                <div id="main" class="layout">
                
                    <div class="layout__main--wide" id="main-content">
                        <div class="block" id="Test-ImgSrc">
                            
                            
    <div class="FulltextWrapper">
        <div class="Categories">
            <div class="ArticleCategory">Research article</div>
            <div class="OpenAccessLabel">Open Access</div>
            
            <div class="OpenPeerReview" data-tooltip-content="open-peer-review-description">Open Peer Review</div>
            
        </div>
        
        <div class="open-peer-review-message" id="open-peer-review-description">
            <p>This article has Open Peer Review reports available.</p>
            <p><a href="/about#peer-review+policy"
                  data-track-event="click"
                  data-event-category="Article Page"
                  data-event-action="Click how does Open Peer Review work?"
                  data-event-label="10.1186/1471-2407-10-401">How does Open Peer Review work?</a></p>
        </div>
        
    </div>

                            <div class="FulltextWrapper"><div xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="MainTitleSection"><h1 xmlns="http://www.w3.org/1999/xhtml" class="ArticleTitle" lang="en">Combined mutations of <em xmlns="" class="EmphasisTypeItalic">ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2</em> and <em xmlns="" class="EmphasisTypeItalic">WT1</em> genes in myelodysplastic syndromes and acute myeloid leukemias</h1></div><div xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="AuthorNames" data-author-affiliations="true"><ul class="u-listReset"><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Julien&nbsp;Rocquain</span><span class="EqualContributionSymbol">†</span><sup><a href="#Aff1" class="AffiliationID">1</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Nadine&nbsp;Carbuccia</span><span class="EqualContributionSymbol">†</span><sup><a href="#Aff1" class="AffiliationID">1</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Virginie&nbsp;Trouplin</span><span class="EqualContributionSymbol">†</span><sup><a href="#Aff1" class="AffiliationID">1</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Stéphane&nbsp;Raynaud</span><sup><a href="#Aff1" class="AffiliationID">1</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Anne&nbsp;Murati</span><sup><a href="#Aff1" class="AffiliationID">1</a>, <a href="#Aff2" class="AffiliationID">2</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Meyer&nbsp;Nezri</span><sup><a href="#Aff3" class="AffiliationID">3</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Zoulika&nbsp;Tadrist</span><sup><a href="#Aff4" class="AffiliationID">4</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Sylviane&nbsp;Olschwang</span><sup><a href="#Aff1" class="AffiliationID">1</a>, <a href="#Aff2" class="AffiliationID">2</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Norbert&nbsp;Vey</span><sup><a href="#Aff5" class="AffiliationID">5</a>, <a href="#Aff6" class="AffiliationID">6</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Daniel&nbsp;Birnbaum</span><sup><a href="#Aff1" class="AffiliationID">1</a></sup>, </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Véronique&nbsp;Gelsi-Boyer</span><sup><a href="#Aff1" class="AffiliationID">1</a>, <a href="#Aff2" class="AffiliationID">2</a>, <a href="#Aff5" class="AffiliationID">5</a></sup> and </li><li class="Author" data-jumpto="Aff"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName">Marie-Joelle&nbsp;Mozziconacci</span><sup><a href="#Aff1" class="AffiliationID">1</a>, <a href="#Aff2" class="AffiliationID">2</a></sup><a href="mailto:mozziconaccimj@marseille.fnclcc.fr" class="EmailAuthor" title="Email author"><span class="ContactIcon" aria-hidden="true"></span><span class="u-srOnly">Email author</span></a></li></ul><div class="AffiliationLegend"><div class="AffiliationLegendLine"><span class="EqualContributionSymbol">†</span>Contributed equally</div></div></div><div xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="ArticleContextInformation"><div class="ContextInformation"><div class="ContextInformationJournalTitles"><span class="ArticleCitation"><span xmlns="http://www.w3.org/1999/xhtml" class="JournalTitle">BMC Cancer</span><span class="ArticleCitation_Year">2010</span><span class="ArticleCitation_Volume"><strong>10</strong>:401</span></span></div><p class="ArticleDOI"><a target="_blank" href="https://doi.org/10.1186/1471-2407-10-401">https://doi.org/10.1186/1471-2407-10-401</a></p><p class="Copyright">© &nbsp;Rocquain et al; licensee BioMed Central Ltd.&nbsp;2010</p></div></div><div class="ArticleHistory"><p class="History HistoryReceived"><strong>Received: </strong>22&nbsp;February&nbsp;2010</p><p class="History HistoryAccepted"><strong>Accepted: </strong>2&nbsp;August&nbsp;2010</p><p class="History HistoryOnlineDate"><strong>Published: </strong>2&nbsp;August&nbsp;2010</p></div></div>
                            
                            
                            
    
    <div class="Message Message--opr u-marginTopL u-marginBtmL">
        <div class="Message_content">
            <p><a href="/articles/10.1186/1471-2407-10-401/open-peer-review"
                  data-track-event="click"
                  data-event-category="Article Page"
                  data-event-action="Click Open Peer Review reports"
                  data-event-label="10.1186/1471-2407-10-401">Open Peer Review reports</a></p>
        </div>
    </div>
    

                            <div class="FulltextWrapper"><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Abstract" id="Abs1" lang="en"><h2 class="Heading js-ToggleCollapseSection">Abstract</h2><div class="js-CollapseSection"><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec1">
                <h3 xmlns="" class="Heading">Background</h3>
                <p class="Para">Gene mutation is an important mechanism of myeloid leukemogenesis. However, the number and combination of gene mutated in myeloid malignancies is still a matter of investigation.</p>
              </div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec2">
                <h3 xmlns="" class="Heading">Methods</h3>
                <p class="Para">We searched for mutations in the <em xmlns="" class="EmphasisTypeItalic">ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2</em> and <em xmlns="" class="EmphasisTypeItalic">WT1</em> genes in 65 myelodysplastic syndromes (MDSs) and 64 acute myeloid leukemias (AMLs) without balanced translocation or complex karyotype.</p>
              </div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec3">
                <h3 xmlns="" class="Heading">Results</h3>
                <p class="Para">Mutations in <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> and <em xmlns="" class="EmphasisTypeItalic">CBL</em> were frequent in refractory anemia with excess of blasts. Mutations in <em xmlns="" class="EmphasisTypeItalic">TET2</em> occurred with similar frequency in MDSs and AMLs and associated equally with either <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> or <em xmlns="" class="EmphasisTypeItalic">NPM1</em> mutations. Mutations of <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> were mutually exclusive with <em xmlns="" class="EmphasisTypeItalic">TET2</em> and combined with <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> but not with <em xmlns="" class="EmphasisTypeItalic">NPM1</em>. Mutations in <em xmlns="" class="EmphasisTypeItalic">FLT3 (</em>mutation and internal tandem duplication), <em xmlns="" class="EmphasisTypeItalic">IDH1</em>, <em xmlns="" class="EmphasisTypeItalic">IDH2</em>, <em xmlns="" class="EmphasisTypeItalic">NPM1</em> and <em xmlns="" class="EmphasisTypeItalic">WT1</em> occurred primarily in AMLs.</p>
              </div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec4">
                <h3 xmlns="" class="Heading">Conclusion</h3>
                <p class="Para">Only 14% MDSs but half AMLs had at least two mutations in the genes studied. Based on the observed combinations and exclusions we classified the 12 genes into four classes and propose a highly speculative model that at least a mutation in one of each class is necessary for developing AML with simple or normal karyotype.</p>
              </div></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec1" class="Section1 RenderAsSection1"><h2 class="Heading js-ToggleCollapseSection">Background</h2><div class="js-CollapseSection"><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">Myeloid leukemogenesis is a complex process that transforms a regulated hematopoietic stem or progenitor cell into a proliferative cell unable to differentiate. Several genetic alterations such as translocations, gene mutations and deletions play a role in this process. Balanced translocations generating gene fusion play a major leukemogenic role in some classes of leukemias. However, they are rare in myelodysplastic syndromes (MDSs) and the majority of adult acute myeloid leukemias (AMLs) have a normal karyotype (NK-AMLs). MDSs are a heterogeneous group of clonal diseases characterized by bone marrow dysplasia, various degrees of cytopenia and a risk of progression to AML [<span class="CitationRef"><a href="#CR1" data-toggle="citation" data-target="CR1">1</a></span>]. The alterations that lead to these pre-leukemic disorders are poorly defined [<span class="CitationRef"><a href="#CR2" data-toggle="citation" data-target="CR2">2</a></span>]. Several genes have been identified recently as mutated in MDSs and AMLs, including <em xmlns="" class="EmphasisTypeItalic">ASXL1</em>, located in chromosome arm 20q, <em xmlns="" class="EmphasisTypeItalic">CBL</em>, located in 11q, and <em xmlns="" class="EmphasisTypeItalic">TET2</em>, located in 4q [<span class="CitationRef"><a href="#CR3" data-toggle="citation" data-target="CR3">3</a></span>–<span class="CitationRef"><a href="#CR11" data-toggle="citation" data-target="CR11">11</a></span>]. These mutations are associated with biological and prognostic features [<span class="CitationRef"><a href="#CR9" data-toggle="citation" data-target="CR9">9</a></span>, <span class="CitationRef"><a href="#CR11" data-toggle="citation" data-target="CR11">11</a></span>].</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">Similarly, gene mutations are likely to play a role in the development of NK-AMLs. Indeed, the identification of mutations in several genes such as <em xmlns="" class="EmphasisTypeItalic">NPM1</em> and <em xmlns="" class="EmphasisTypeItalic">FLT3</em> has revealed prognosis subgroups and modified the clinical management of these leukemias [<span class="CitationRef"><a href="#CR12" data-toggle="citation" data-target="CR12">12</a></span>, <span class="CitationRef"><a href="#CR13" data-toggle="citation" data-target="CR13">13</a></span>]. A recent whole-genome sequencing study of an AML case has revealed mutations in <em xmlns="" class="EmphasisTypeItalic">IDH1</em>, which encodes the enzyme isocitrate dehydrogenase [<span class="CitationRef"><a href="#CR14" data-toggle="citation" data-target="CR14">14</a></span>]. AMLs occur <em xmlns="" class="EmphasisTypeItalic">de novo</em> or after a chronic phase (hereafter called primary and secondary, respectively). Such chronic phase can be an MDS. We have recently shown that mutations in <em xmlns="" class="EmphasisTypeItalic">ASXL1</em>, in contrast to <em xmlns="" class="EmphasisTypeItalic">NPM1</em> mutations, are found in MDSs and in secondary AMLs [<span class="CitationRef"><a href="#CR15" data-toggle="citation" data-target="CR15">15</a></span>].</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">Mutation data are in line with the multi-hit model proposed by Gilliland suggesting that many gene mutations play a role in leukemogenesis [<span class="CitationRef"><a href="#CR16" data-toggle="citation" data-target="CR16">16</a></span>]. Now that more and more gene mutations are reported it is important to determine when they occur in the various types of malignant hematopoietic diseases and how they combine in the development of leukemia. To begin to answer these questions we searched for mutations in twelve selected genes in a panel of 129 MDS and AML samples.</p></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec2" class="Section1 RenderAsSection1"><h2 class="Heading js-ToggleCollapseSection">Methods</h2><div class="js-CollapseSection"><section id="Sec3" class="Section2 RenderAsSection2">
                <h3 class="Heading">Patients and samples</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">All patients signed an informed consent and the study was approved by the institutional review board ("Commission d'Orientation Scientifique") of Institut Paoli-Calmettes.</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">The 129 samples were selected on the absence of known balanced translocation, and in the absence of complex karyotype for the AML series (as defined by more than three alterations). They included 65 cases of MDS (Additional file <span class="InternalRef"><a href="#MOESM1">1</a></span> <strong xmlns="" class="EmphasisTypeBold">Table S1</strong>), comprising, according to the WHO criteria [<span class="CitationRef"><a href="#CR17" data-toggle="citation" data-target="CR17">17</a></span>], 5 refractory anemia (RA), 13 refractory anemia with ring sideroblasts (RARS) (including one with myelofibrosis), 7 refractory cytopenia with multilineage dysplasia (RCMD), 16 refractory anemia with excess of blasts type 1 (RAEB1), 19 refractory anemia with excess of blasts type 2 (RAEB2) and 5 MDS-unclassified (MDS-U) cases. Six cases were secondary to hematopoietic or non-hematopoietic diseases (na in IPSS column, Additional file <span class="InternalRef"><a href="#MOESM2">2</a></span> <strong xmlns="" class="EmphasisTypeBold">Table S1</strong>). The majority of MDS samples were collected at the time of diagnosis; some were in therapeutic abstention of a known MDS and some were under symptomatic treatment. Seventeen cases were IPPS low risk (0), 23 were int-1 (0.5-1), 12 were int-2 (1.5-2) and 7 were high risk (≥2.5).</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">We studied 64 AMLs (Additional file <span class="InternalRef"><a href="#MOESM2">2</a></span> <strong xmlns="" class="EmphasisTypeBold">Table S2</strong>) including 46 primary cases and 18 transformations of a previous myeloid disease (the same cohort of 64 AML patients, listed in Additional file <span class="InternalRef"><a href="#MOESM2">2</a></span> <strong xmlns="" class="EmphasisTypeBold">Table S2</strong>, had been analyzed for mutations in the <em xmlns="" class="EmphasisTypeItalic">NPM1, FLT3, CEBPA, NRAS, KRAS, JAK2</em>, and <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> genes and the results already reported in ref. 15). The panel comprised 47 cases of NK-AML and 17 cases with either trisomy 8 (n = 14), 9q deletion (HD-0632), trisomy 11 (HD-0304) or 20q deletion (HD-0381) as a sole karyotypic abnormality.</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">Array-comparative genomic hybridization (aCGH) had been performed on almost all samples and had allowed the detection of deletions and breaks [<span class="CitationRef"><a href="#CR9" data-toggle="citation" data-target="CR9">9</a></span>, <span class="CitationRef"><a href="#CR10" data-toggle="citation" data-target="CR10">10</a></span>, <span class="CitationRef"><a href="#CR15" data-toggle="citation" data-target="CR15">15</a></span>, <span class="CitationRef"><a href="#CR18" data-toggle="citation" data-target="CR18">18</a></span>, <span class="CitationRef"><a href="#CR19" data-toggle="citation" data-target="CR19">19</a></span>].</p>
              </section><section id="Sec4" class="Section2 RenderAsSection2">
                <h3 class="Heading">DNA sequencing</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">DNA sequencing of exon-coding sequences of <em xmlns="" class="EmphasisTypeItalic">ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2</em> and <em xmlns="" class="EmphasisTypeItalic">WT1</em> was done as follows. PCR amplifications of bone marrow cell DNA were done in a total volume of 25 μl PCR mix containing at least 5 ng template DNA, Taq buffer, 200 μmol of each deoxynucleotide triphosphate, 20 pmol of each primer and 1 unit of Hot Star Taq (Qiagen). PCR amplification conditions were as follows: 95°C 10 min; 95°C 30 sec, 55°C 30 sec, 72°C 30 sec to 1 min depending on PCR product length for 35 cycles; 72°C 10 min. PCR products were purified using Millipore plate MSNU030. One microliter of the purified PCR products was used for sequencing using the Big Dye terminator v1.1 kit (Applied Biosystems) including the forward or reverse primer. After G50 purification, sequences were loaded on an ABI 3130XL automat (Applied Biosystems). The sequence data files were analyzed using both SeqScape and Phred/Phrap/Consed softwares and all mutations were confirmed on an independent PCR product. The exons studied were as follows: <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> exon 12, <em xmlns="" class="EmphasisTypeItalic">CBL</em> exons 8 and 9, <em xmlns="" class="EmphasisTypeItalic">FLT3</em> exons 14, 15 and 20, <em xmlns="" class="EmphasisTypeItalic">IDH</em> exon 4, <em xmlns="" class="EmphasisTypeItalic">JAK2</em> exon 14, <em xmlns="" class="EmphasisTypeItalic">RAS</em> exons 1 and 2, <em xmlns="" class="EmphasisTypeItalic">NPM1</em> exon 12, <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> exons 1 to 8, <em xmlns="" class="EmphasisTypeItalic">TET2</em> exons 3 to 11, <em xmlns="" class="EmphasisTypeItalic">WT1</em> exons 7 and 9. The primers for sequencing are listed in [Additional file <span class="InternalRef"><a href="#MOESM3">3</a></span>].</p>
              </section></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec5" class="Section1 RenderAsSection1"><h2 class="Heading js-ToggleCollapseSection">Results</h2><div class="js-CollapseSection"><section id="Sec6" class="Section2 RenderAsSection2">
                <h3 class="Heading">Mutations in MDSs</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">We had previously shown that <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> frameshift and nonsense mutations occurred in exon 12 [<span class="CitationRef"><a href="#CR10" data-toggle="citation" data-target="CR10">10</a></span>]. <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> exon 12 frameshift mutations (10 times the same p.Gly646Trpfsx12) were observed in 12 out of the 65 MDS cases (18.5%) including 1 out of 5 RA (20%), 2 out of 16 RAEB1 (12.5%) and 9 out of 19 RAEB2 (47.4%) (Additional file <span class="InternalRef"><a href="#MOESM1">1</a></span> <strong xmlns="" class="EmphasisTypeBold">Table S1</strong>). We found 12 cases with <em xmlns="" class="EmphasisTypeItalic">TET2</em> mutation (18.5%) and 4 with <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> mutation (6.2%). One patient (HD-0311) had two <em xmlns="" class="EmphasisTypeItalic">TET2</em> mutations. <em xmlns="" class="EmphasisTypeItalic">TET2</em> mutations were frequent in RAEB1 (7/16, 43.8%). Mutations in <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> and <em xmlns="" class="EmphasisTypeItalic">TET2</em> were mutually exclusive but both could associate with <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> mutations: two cases showed both an <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> and a <em xmlns="" class="EmphasisTypeItalic">TET2</em> mutation and three cases both an <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> and a <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> mutation. One case of <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> deletion (HD-0190) and one case of <em xmlns="" class="EmphasisTypeItalic">TET2</em> deletion (HD-0145) have been reported [<span class="CitationRef"><a href="#CR9" data-toggle="citation" data-target="CR9">9</a></span>, <span class="CitationRef"><a href="#CR10" data-toggle="citation" data-target="CR10">10</a></span>]. One case (HD-0232) had a break in <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> detected by aCGH (not shown).</p>
                <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">We did not find any <em xmlns="" class="EmphasisTypeItalic">FLT3, NPM1</em> or <em xmlns="" class="EmphasisTypeItalic">WT1</em> mutation. One MDS-U had a <em xmlns="" class="EmphasisTypeItalic">JAK2</em> mutation and one RCMD case a <em xmlns="" class="EmphasisTypeItalic">KRAS</em> mutation. Five cases, all RAEB2, were mutated in <em xmlns="" class="EmphasisTypeItalic">CBL</em>. In one of these the mutation was homozygous. One subtitution occurred in the case with trisomy 11 (HD-0264), and showed a 2/3 ratio with the wild-type residue, suggesting that the mutated allele was duplicated (Figure <span class="InternalRef"><a href="#Fig1">1a</a></span>). This is in agreement with a potential gain-of-function of the mutated CBL [<span class="CitationRef"><a href="#CR20" data-toggle="citation" data-target="CR20">20</a></span>]. We found 5 IDH mutations in the 65 cases (7.7%), including 2 mutations in <em xmlns="" class="EmphasisTypeItalic">IDH1</em> and 3 in <em xmlns="" class="EmphasisTypeItalic">IDH2</em>.<figure xmlns="" class="Figure" id="Fig1"><div xmlns="http://www.w3.org/1999/xhtml" class="MediaObject">
                      <a target="_blank" href="http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_Article_2200_Fig1_HTML.jpg"><img src="http://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_Article_2200_Fig1_HTML.jpg"></img></a>
                    </div><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Figure 1</span>
                        <p xmlns="" class="SimplePara">
<strong class="EmphasisTypeBold">Examples of mutations in leukemia target genes</strong>. a. sequence of <em class="EmphasisTypeItalic">CBL</em> demonstrating c.1096G&gt;A base substitution in the forward sequence at the position indicated by an arrow in HD-0264 patient with trisomy 11. The mutation leads to Glu366Lys change in the protein (not tolerated, SIFT). Sequence numbering is according to Genbank accessions numbers NM_005188 and NP_005179. The same sequence from another patient without mutation is shown below for comparison. b. Novel IDH2 mutation in MDS and AML patients. Sequence of <em class="EmphasisTypeItalic">IDH2</em>, demonstrating c.419G&gt;A base substitution in the reverse sequence at the position indicated by an arrow in blood cells of patient HD-0104 and its absence in the patient's buccal smear. The mutation leads to Arg140Gln (R140Q) change in the protein (not tolerated, SIFT). Sequence numbering is according to Genbank accessions numbers NM_002168.2 and NP_002159.2.</p>
                      </div></figcaption></figure>
</div>
              </section><section id="Sec7" class="Section2 RenderAsSection2">
                <h3 class="Heading">Mutations in AMLs</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">We found heterozygous nonsense or frameshift mutations of <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> in 11 out of the 64 cases and one case (HD-0381) was known to have a deletion (Additional file <span class="InternalRef"><a href="#MOESM2">2</a></span> <strong xmlns="" class="EmphasisTypeBold">Table S2</strong>) [<span class="CitationRef"><a href="#CR15" data-toggle="citation" data-target="CR15">15</a></span>]. As previously shown [<span class="CitationRef"><a href="#CR15" data-toggle="citation" data-target="CR15">15</a></span>]<em xmlns="" class="EmphasisTypeItalic">NPM1</em> mutations were found in 28 cases, mostly primary cases. We found 9 <em xmlns="" class="EmphasisTypeItalic">TET2</em> mutations in 9 cases, and 10 <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> mutations in 9 cases (HD-0790 had two <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> mutations). In addition, HD-0198 had a break in <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> [<span class="CitationRef"><a href="#CR19" data-toggle="citation" data-target="CR19">19</a></span>]. These alterations were found in both primary and secondary AMLs. Mutations in <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> and <em xmlns="" class="EmphasisTypeItalic">TET2</em>, <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> and <em xmlns="" class="EmphasisTypeItalic">NPM1</em>, and <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> and <em xmlns="" class="EmphasisTypeItalic">NPM1</em> were mutually exclusive, respectively. <em xmlns="" class="EmphasisTypeItalic">TET2</em> mutations could associate with either mutated <em xmlns="" class="EmphasisTypeItalic">NPM1</em> or <em xmlns="" class="EmphasisTypeItalic">ASXL1</em>.</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">Nineteen cases (mostly primary) had <em xmlns="" class="EmphasisTypeItalic">FLT3</em> internal tandem duplication or point mutation. Three cases had a <em xmlns="" class="EmphasisTypeItalic">RAS</em> mutation and one a JAK2 V617F mutation. The only <em xmlns="" class="EmphasisTypeItalic">CBL</em> mutation was found in the case with a trisomy 11 (HD-0304, the corresponding transformed state of HD-0264 MDS). Three primary cases (6.5%) showed a <em xmlns="" class="EmphasisTypeItalic">WT1</em> mutation. Three cases were mutated in <em xmlns="" class="EmphasisTypeItalic">IDH1</em>. Four cases showed the Arg172Lys mutation in IDH2. We also found 11 cases (17%) with the Arg140Gln substitution in IDH2 (Figure <span class="InternalRef"><a href="#Fig1">1b</a></span>).</p>
              </section><section id="Sec8" class="Section2 RenderAsSection2">
                <h3 class="Heading">Paired cases</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">For two patients both the chronic (HD-0173, HD-0264) and acute (HD-0790, HD-0304) phases of the disease were available (in bold in Tables). RARS HD-0173 had a mutated <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> allele. The corresponding AML (HD-0790) had two <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> mutations. RAEB2 HD-0264 had a mutation in <em xmlns="" class="EmphasisTypeItalic">ASXL1, CBL</em> and <em xmlns="" class="EmphasisTypeItalic">TET2</em> genes. In the corresponding AML we did not identify any additional mutation in the studied genes.</p>
              </section><section id="Sec9" class="Section2 RenderAsSection2">
                <h3 class="Heading">Summary of results</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">Additional file <span class="InternalRef"><a href="#MOESM4">4</a></span> <strong xmlns="" class="EmphasisTypeBold">Table S3</strong> shows a summary of the results on mutated (cases with two mutations are counted as one) and deleted/broken cases. Mutations of <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> were frequent in MDSs and secondary AMLs. Mutations of <em xmlns="" class="EmphasisTypeItalic">TET2</em> occurred with a similar frequency in MDSs and AMLs. <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> and <em xmlns="" class="EmphasisTypeItalic">CBL</em> mutations were associated with chronic phase, mainly RAEB2. Overall, advanced stage MDSs had more mutations. <em xmlns="" class="EmphasisTypeItalic">NPM1</em>, <em xmlns="" class="EmphasisTypeItalic">FLT3</em> and <em xmlns="" class="EmphasisTypeItalic">WT1</em> mutations were associated with primary AMLs. Mutations of <em xmlns="" class="EmphasisTypeItalic">IDH1/2</em> were rare in chronic phase. Not surprisingly, the number of mutated genes per case was lower in MDSs than in AMLs: only 14% MDSs but more than half AMLs had at least two gene mutations.</p>
              </section></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec10" class="Section1 RenderAsSection1"><h2 class="Heading js-ToggleCollapseSection">Discussion</h2><div class="js-CollapseSection"><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">We searched for mutations in a series of selected genes. Mutations in some of these genes, such as <em xmlns="" class="EmphasisTypeItalic">ASXL1, CBL, IDH</em> and <em xmlns="" class="EmphasisTypeItalic">TET2</em>, have been identified only recently in myeloid diseases and have never been surveyed together to date. A number of issues need be discussed.</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">The frequencies of mutations we observed are close to what has been reported individually for each gene so far. This is true for example for <em xmlns="" class="EmphasisTypeItalic">IDH1</em>, <em xmlns="" class="EmphasisTypeItalic">NPM1</em>, <em xmlns="" class="EmphasisTypeItalic">TET2</em> and <em xmlns="" class="EmphasisTypeItalic">WT1</em> [<span class="CitationRef"><a href="#CR1" data-toggle="citation" data-target="CR1">1</a></span>, <span class="CitationRef"><a href="#CR3" data-toggle="citation" data-target="CR3">3</a></span>–<span class="CitationRef"><a href="#CR9" data-toggle="citation" data-target="CR9">9</a></span>, <span class="CitationRef"><a href="#CR14" data-toggle="citation" data-target="CR14">14</a></span>, <span class="CitationRef"><a href="#CR21" data-toggle="citation" data-target="CR21">21</a></span>, <span class="CitationRef"><a href="#CR22" data-toggle="citation" data-target="CR22">22</a></span>]. In MDS we found slightly more mutations of <em xmlns="" class="EmphasisTypeItalic">CBL</em> than previously reported [<span class="CitationRef"><a href="#CR11" data-toggle="citation" data-target="CR11">11</a></span>]. The IDH2 Arg140Gln was frequent in AMLs, rare in MDSs. The mutation was not present in the buccal smear DNA of a patient with AML (HD-0104), showing it was acquired. The Arg140Gln mutation in IDH2 has been reported in recent studies of myeloid diseases [<span class="CitationRef"><a href="#CR23" data-toggle="citation" data-target="CR23">23</a></span>, <span class="CitationRef"><a href="#CR24" data-toggle="citation" data-target="CR24">24</a></span>]. A recent study has described <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> as the most frequently mutated gene in advanced MDSs [<span class="CitationRef"><a href="#CR25" data-toggle="citation" data-target="CR25">25</a></span>], which we confirmed here.</p><section id="Sec11" class="Section2 RenderAsSection2">
                <h3 class="Heading">A repertoire of mutations</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">Based on the known functions of the proteins, on a previous model and classification [<span class="CitationRef"><a href="#CR16" data-toggle="citation" data-target="CR16">16</a></span>], on where the mutations were present (MDSs and/or secondary AMLs and/or primary AMLs) and on how they combined (mutual exclusion or association), we tentatively grouped the genes in four classes. The first class includes <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> and <em xmlns="" class="EmphasisTypeItalic">TET2</em>. Mutations in these genes may cause clonal dominance of hematopoietic stem cells [<span class="CitationRef"><a href="#CR3" data-toggle="citation" data-target="CR3">3</a></span>]. <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> and <em xmlns="" class="EmphasisTypeItalic">NPM1</em> would constitute class II. Mutations in these genes may promote a pathway leading towards either primary or secondary AML [<span class="CitationRef"><a href="#CR15" data-toggle="citation" data-target="CR15">15</a></span>]. Genes associated with signaling pathways and proliferation [<span class="CitationRef"><a href="#CR16" data-toggle="citation" data-target="CR16">16</a></span>] (<em xmlns="" class="EmphasisTypeItalic">CBL, FLT3, JAK2, RAS</em>) define class III. <em xmlns="" class="EmphasisTypeItalic">JAK2</em> mutation plays little role in MDSs and NK-AMLs. We have shown that FLT3 signaling is regulated by CBL [<span class="CitationRef"><a href="#CR26" data-toggle="citation" data-target="CR26">26</a></span>]. However, the two alterations may not be equivalent; if in our study mutations in these genes were mutually exclusive and were both more frequent in AMLs than in MDSs, <em xmlns="" class="EmphasisTypeItalic">CBL</em> but not <em xmlns="" class="EmphasisTypeItalic">FLT3</em> mutations were frequent in RAEB2 cases. This is in agreement with recent studies that showed alterations of <em xmlns="" class="EmphasisTypeItalic">CBL</em> in chronic myeloid diseases [<span class="CitationRef"><a href="#CR11" data-toggle="citation" data-target="CR11">11</a></span>, <span class="CitationRef"><a href="#CR27" data-toggle="citation" data-target="CR27">27</a></span>]. Finally, for three reasons we grouped <em xmlns="" class="EmphasisTypeItalic">IDH1</em>, <em xmlns="" class="EmphasisTypeItalic">IDH2</em>, and <em xmlns="" class="EmphasisTypeItalic">WT1</em> in a putative class IV. First, <em xmlns="" class="EmphasisTypeItalic">IDH</em> and <em xmlns="" class="EmphasisTypeItalic">WT1</em> mutations were exclusive but could co-occur with mutations in genes from other classes. Second, they occurred primarily in AMLs and were rare in MDSs. Third, mutations of these genes could be associated with modifications of the HIF1 and oxygen-sensing pathways [<span class="CitationRef"><a href="#CR28" data-toggle="citation" data-target="CR28">28</a></span>, <span class="CitationRef"><a href="#CR29" data-toggle="citation" data-target="CR29">29</a></span>]. Class IV mutations are rather associated with acute phase.</p>
                <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">The existence of many cases with few or no mutations in the selected genes, especially in some classes of MDSs such as MDS-U, RA, RARS and RCMD but also in primary AMLs (half of the cases with no or one mutation), suggests that other genes remain to be studied or discovered. Indeed, our study did not include several target genes, such as <em xmlns="" class="EmphasisTypeItalic">CBFB</em> [<span class="CitationRef"><a href="#CR30" data-toggle="citation" data-target="CR30">30</a></span>], <em xmlns="" class="EmphasisTypeItalic">CDKN1A/B</em>, <em xmlns="" class="EmphasisTypeItalic">CEBPA</em>, <em xmlns="" class="EmphasisTypeItalic">ETV6</em>, <em xmlns="" class="EmphasisTypeItalic">KIT</em>, <em xmlns="" class="EmphasisTypeItalic">NF1</em>, <em xmlns="" class="EmphasisTypeItalic">NFIA</em> [<span class="CitationRef"><a href="#CR31" data-toggle="citation" data-target="CR31">31</a></span>], <em xmlns="" class="EmphasisTypeItalic">P53, RB1</em> and <em xmlns="" class="EmphasisTypeItalic">UTX</em> [<span class="CitationRef"><a href="#CR32" data-toggle="citation" data-target="CR32">32</a></span>]; it did not include either a search for the recently discovered mutations of the <em xmlns="" class="EmphasisTypeItalic">EZH2</em> gene [<span class="CitationRef"><a href="#CR33" data-toggle="citation" data-target="CR33">33</a></span>, <span class="CitationRef"><a href="#CR34" data-toggle="citation" data-target="CR34">34</a></span>]. Moreover, our aCGH analyses of the same series showed that some cases without mutation in the studied genes do have deletions of other cancer genes (for example <em xmlns="" class="EmphasisTypeItalic">CDKN1B, ETV6</em> and <em xmlns="" class="EmphasisTypeItalic">UTX</em> [<span class="CitationRef"><a href="#CR32" data-toggle="citation" data-target="CR32">32</a></span>] are deleted in HD-0205) [<span class="CitationRef"><a href="#CR9" data-toggle="citation" data-target="CR9">9</a></span>, <span class="CitationRef"><a href="#CR10" data-toggle="citation" data-target="CR10">10</a></span>, <span class="CitationRef"><a href="#CR15" data-toggle="citation" data-target="CR15">15</a></span>]. Thus, the repertoire of altered genes in both MDSs and AMLs is likely to include many genes and it is probable that whole-genome sequencing studies will confirm this. Because of this, and although no case had four mutations, we propose that AML develops following - at least - four cooperating mutations, one from each class (Figure <span class="InternalRef"><a href="#Fig2">2</a></span>). This is highly speculative however; the identification of new target genes and the study of others will lead to a more precise picture. Also, because we did not study AMLs with balanced translocation or complex karyotype this model is proposed only for AML with simple or normal karyotype.<figure xmlns="" class="Figure" id="Fig2"><div xmlns="http://www.w3.org/1999/xhtml" class="MediaObject">
                      <a target="_blank" href="http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_Article_2200_Fig2_HTML.jpg"><img src="http://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_Article_2200_Fig2_HTML.jpg"></img></a>
                    </div><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Figure 2</span>
                        <p xmlns="" class="SimplePara">
<strong class="EmphasisTypeBold">Hypothetical model summarizing frequent gene mutations in the development of two types of acute myeloid leukemia (AML)</strong>. A hematopoietic stem cell (HSC) or a progenitor cell acquires a series of mutations beginning in class I genes (green). Different additional events (yellow, red and blue) induce clonal expansion and differentiation block and lead either towards secondary AML (sAML) via a patent preleukemic phase or AML without patent preleukemic phase. The order of events may vary.</p>
                      </div></figcaption></figure>
</div>
              </section><section id="Sec12" class="Section2 RenderAsSection2">
                <h3 class="Heading">Random or ordered accumulation?</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">An important question is whether the mutations occur in a necessary order or randomly until differentiation of the malignant hematopoietic clone is completely blocked. RARS HD-0173 (one <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> mutation) and AML HD-0790 (two <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> mutations) are instructive samples from the same patient. It is tempting to interpret this observation as a bi-allelic inactivation of the <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> gene. <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> mutations are frequent in chronic myelomonocytic leukemia [<span class="CitationRef"><a href="#CR19" data-toggle="citation" data-target="CR19">19</a></span>] but rare in myeloproliferative neoplasms except at the acute phase [<span class="CitationRef"><a href="#CR35" data-toggle="citation" data-target="CR35">35</a></span>]. In our series, mutations in <em xmlns="" class="EmphasisTypeItalic">TET2</em> were equally frequent in MDSs and AMLs. Taken together this suggests that inactivation of class I tumor suppressors (<em xmlns="" class="EmphasisTypeItalic">RUNX1, TET2</em>) can intervene at any stage, i.e. early or at progression. In studies of AMLs secondary to myeloproliferative neoplasms (MPN) mutations of <em xmlns="" class="EmphasisTypeItalic">TET2</em> have indeed been shown to occur early or late [<span class="CitationRef"><a href="#CR30" data-toggle="citation" data-target="CR30">30</a></span>, <span class="CitationRef"><a href="#CR36" data-toggle="citation" data-target="CR36">36</a></span>]. A recent study showed that <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> mutations were present at the chronic stage and, in agreement with our findings, that <em xmlns="" class="EmphasisTypeItalic">ASXL1</em>, <em xmlns="" class="EmphasisTypeItalic">JAK2</em> and <em xmlns="" class="EmphasisTypeItalic">TET2</em> have non overlapping contributions to myeloid transformation [<span class="CitationRef"><a href="#CR36" data-toggle="citation" data-target="CR36">36</a></span>]. The order of occurrence of <em xmlns="" class="EmphasisTypeItalic">ASXL1</em>, <em xmlns="" class="EmphasisTypeItalic">TET2</em> and <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> mutations may vary in different diseases (MPNs and MDSs) and in different patients. However, the number of paired cases was much too low in our series to draw any firm conclusion. The study of more paired cases is necessary to definitely clear this issue. In contrast, some mutations such as <em xmlns="" class="EmphasisTypeItalic">IDH1</em> and <em xmlns="" class="EmphasisTypeItalic">IDH2</em> amino acid changes were detected at the AML rather than the MDS stage. Mutations in proliferation genes - except in <em xmlns="" class="EmphasisTypeItalic">CBL</em> - were rare in MDS. Taken together this suggests that mutations in classes III and IV may occur late in leukemogenesis.</p>
              </section><section id="Sec13" class="Section2 RenderAsSection2">
                <h3 class="Heading">Myeloid malignancies and cancer genes</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">The study of myeloid malignancies may modify the classical view of cancer gene inactivation. <em xmlns="" class="EmphasisTypeItalic">IDH1</em> mutations do not result in a loss but in a change in activity [<span class="CitationRef"><a href="#CR37" data-toggle="citation" data-target="CR37">37</a></span>]. This is in agreement with the fact that, in contrast to <em xmlns="" class="EmphasisTypeItalic">ASXL1, RUNX1</em> and <em xmlns="" class="EmphasisTypeItalic">TET2</em>, we never observed break or deletion at <em xmlns="" class="EmphasisTypeItalic">IDH</em> loci by aCGH analysis. <em xmlns="" class="EmphasisTypeItalic">WT1</em> is mutated but also overexpressed in AMLs. Mutations in <em xmlns="" class="EmphasisTypeItalic">CBL</em> are associated with a gain-of-function [<span class="CitationRef"><a href="#CR20" data-toggle="citation" data-target="CR20">20</a></span>]. <em xmlns="" class="EmphasisTypeItalic">NPM1</em> overexpression leads to increased cell growth [<span class="CitationRef"><a href="#CR38" data-toggle="citation" data-target="CR38">38</a></span>]. We have not so far found two mutations (or mutation and deletion) in <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> in the same sample. It is possible that <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> mutations are also associated with a gain-of-function [<span class="CitationRef"><a href="#CR39" data-toggle="citation" data-target="CR39">39</a></span>]. Only <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> and <em xmlns="" class="EmphasisTypeItalic">TET2</em> may be inactivated in the two-hit fashion that corresponds to "classical" tumor suppressors.</p>
              </section><section id="Sec14" class="Section2 RenderAsSection2">
                <h3 class="Heading">Impact of mutations on prognosis</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">Due to relatively small numbers our purpose was not to address prognosis issues. Besides, it may be illusory to study prognostic impact of tumor suppressors in the absence of knowledge of yet unknown genes that may serve the same function. However, some features could be briefly noted. In contrast to <em xmlns="" class="EmphasisTypeItalic">TET2</em> mutations, which were relatively evenly distributed among IPSS classes, <em xmlns="" class="EmphasisTypeItalic">ASXL1</em>, <em xmlns="" class="EmphasisTypeItalic">CBL</em> and <em xmlns="" class="EmphasisTypeItalic">IDH</em> mutations were associated with more aggressive MDSs. Lower risk MDSs had fewer mutations of these genes than higher risk MDSs. Half of the 12 MDS with int-2 IPSS showed <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> mutations, and reciprocally half of the <em xmlns="" class="EmphasisTypeItalic">ASXL1</em> mutations were in int-2 cases. Four <em xmlns="" class="EmphasisTypeItalic">CBL</em> mutations were found in int-2 cases. The 7 MDSs with high IPSS had an abnormal karyotype but few mutations (<em xmlns="" class="EmphasisTypeItalic">ASXL1</em> and <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> in HD-0377, <em xmlns="" class="EmphasisTypeItalic">CBL</em> in HD-0193); this is not surprising since karyotype status has an important weight on IPSS as one of its components. A long follow-up on disease evolution should tell if and how the mutational status impacts on MDS progression to AML and should be used to fine-tune IPSS.</p>
              </section></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec15" class="Section1 RenderAsSection1"><h2 class="Heading js-ToggleCollapseSection">Conclusion</h2><div class="js-CollapseSection"><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">We have reported here the first comprehensive study including recently discovered gene mutations in MDSs and AMLs. We have proposed a speculative model of cooperative leukemogenesis for AML with simple or normal karyotype, which needs to be confirmed by the study of more cases and completed by the discovery of more genes. As this it represents a step towards the necessary determination of the complete mutational status of myeloid malignant diseases.</p></div></section>
          <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 ArticleNotes" id="ArticleNotes"><h2 class="Heading js-ToggleCollapseSection">Notes</h2><div class="js-CollapseSection"><aside xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="ArticleNote ArticleNoteMisc"><p xmlns="" class="SimplePara">Julien Rocquain, Nadine Carbuccia, Virginie Trouplin contributed equally to this work.</p></aside></div></section><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1" id="Declarations"><h2 class="Heading js-ToggleCollapseSection">
              Declarations
            </h2><div class="js-CollapseSection"><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Acknowledgments"><h3 xmlns="" class="Heading">Acknowledgements</h3><p xmlns="" class="SimplePara">We are very grateful to the patients who participated to the study. This work was supported by Inserm, Institut Paoli-Calmettes and grants from the Fondation de France (DB, Comité Leucémie 2007-2009) and Association pour la Recherche contre le Cancer (n° 4929; n° 4992).</p></div><aside class="Appendix" id="App1">
              
                <h3 class="Heading">Electronic supplementary material</h3><div id="widgetContainer"></div>
                <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">
                  <div class="MediaObject" id="MOESM1">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a class="filename" href="https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_2200_MOESM1_ESM.XLS">12885_2010_2200_MOESM1_ESM.XLS</a>
                          <span xmlns="" class="SimplePara">Additional file 1: Table S1 Mutations of candidate genes in a series of myelodysplastic syndromes. (XLS )</span>
                        </div></div>
                  </div>
                  <div class="MediaObject" id="MOESM2">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a class="filename" href="https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_2200_MOESM2_ESM.PDF">12885_2010_2200_MOESM2_ESM.PDF</a>
                          <span xmlns="" class="SimplePara">Additional file 2: Table S2 Mutations of candidate genes in a series of AMLs. (PDF 14 KB)</span>
                        </div></div>
                  </div>
                  <div class="MediaObject" id="MOESM3">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a class="filename" href="https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_2200_MOESM3_ESM.PDF">12885_2010_2200_MOESM3_ESM.PDF</a>
                          <span xmlns="" class="SimplePara">Additional file 3: Oligonucleotide primers used for sequencing the coding regions of the selected genes. (PDF )</span>
                        </div></div>
                  </div>
                  <div class="MediaObject" id="MOESM4">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a class="filename" href="https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_2200_MOESM4_ESM.PDF">12885_2010_2200_MOESM4_ESM.PDF</a>
                          <span xmlns="" class="SimplePara">Additional file 4: Table S3 Summary of results.(PDF 24 KB)</span>
                        </div></div>
                  </div>
                </div>
              
              
                
                <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Para">Below are the links to the authors’ original submitted files for images.<div class="MediaObject" id="MOESM5">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a class="filename" href="https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_2200_MOESM5_ESM.pdf">12885_2010_2200_MOESM5_ESM.pdf</a>
                          <span xmlns="" class="SimplePara">Authors’ original file for figure 1</span>
                        </div></div>
                  </div>
<div class="MediaObject" id="MOESM6">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a class="filename" href="https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_2200_MOESM6_ESM.pdf">12885_2010_2200_MOESM6_ESM.pdf</a>
                          <span xmlns="" class="SimplePara">Authors’ original file for figure 2</span>
                        </div></div>
                  </div>
<div class="MediaObject" id="MOESM7">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a class="filename" href="https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_2200_MOESM7_ESM.pdf">12885_2010_2200_MOESM7_ESM.pdf</a>
                          <span xmlns="" class="SimplePara">Authors’ original file for figure 3</span>
                        </div></div>
                  </div>
<div class="MediaObject" id="MOESM8">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a class="filename" href="https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_2200_MOESM8_ESM.pdf">12885_2010_2200_MOESM8_ESM.pdf</a>
                          <span xmlns="" class="SimplePara">Authors’ original file for figure 4</span>
                        </div></div>
                  </div>
<div class="MediaObject" id="MOESM9">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a class="filename" href="https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-10-401/MediaObjects/12885_2010_2200_MOESM9_ESM.pdf">12885_2010_2200_MOESM9_ESM.pdf</a>
                          <span xmlns="" class="SimplePara">Authors’ original file for figure 5</span>
                        </div></div>
                  </div>
</div>
              
            </aside><aside xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="ArticleNote ArticleNoteMisc"><h3 xmlns="" class="Heading">Competing interests</h3><p xmlns="" class="SimplePara">The authors declare that they have no competing interests.</p></aside><aside xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="ArticleNote ArticleNoteMisc"><h3 xmlns="" class="Heading">Authors' contributions</h3><p xmlns="" class="SimplePara">JR, NC, VT, SR and SO obtained and analyzed gene sequencing data. AM, MN, ZT, VGB; MJM and NV provided samples and bioclinical data. NV, DB, VGB and MJM designed and supervised the study, analyzed the data and wrote the manuscript. All authors read and approved the final manuscript.</p></aside></div></section></div>
                            <div class="FulltextWrapper"><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 Affiliations" id="Aff"><h2 class="Heading js-ToggleCollapseSection">Authors’ Affiliations</h2><div class="js-CollapseSection"><div class="Affiliation" id="Aff1"><span class="AffiliationNumber">(1)</span><div class="AffiliationText">Centre de Recherche en Cancérologie de Marseille, Laboratoire d'Oncologie Moléculaire; UMR891 Inserm; Institut Paoli-Calmettes</div></div><div class="Affiliation" id="Aff2"><span class="AffiliationNumber">(2)</span><div class="AffiliationText">Département de BioPathologie, Institut Paoli-Calmettes</div></div><div class="Affiliation" id="Aff3"><span class="AffiliationNumber">(3)</span><div class="AffiliationText">Service de Médecine Interne, Centre Hospitalier Général</div></div><div class="Affiliation" id="Aff4"><span class="AffiliationNumber">(4)</span><div class="AffiliationText">Service de Médecine Interne-Oncologie, Hôpital de Salon-de-Provence</div></div><div class="Affiliation" id="Aff5"><span class="AffiliationNumber">(5)</span><div class="AffiliationText">Faculté de Médecine, Université de la Méditerranée</div></div><div class="Affiliation" id="Aff6"><span class="AffiliationNumber">(6)</span><div class="AffiliationText">Département d'Hématologie, Institut Paoli-Calmettes</div></div></div></section></div>
                            <div class="FulltextWrapper"><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 SectionTypeMaterialsAndMethods" id="Bib1"><h2 class="Heading js-ToggleCollapseSection">References</h2><div class="js-CollapseSection"><ol class="BibliographyWrapper"><li class="Citation"><cite class="CitationContent" id="CR1">Tefferi A, Vardiman JW: Myelodysplastic syndromes. N Eng J Med. 2009, 361: 1872-1885. 10.1056/NEJMra0902908.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1056/NEJMra0902908"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Myelodysplastic%20syndromes&amp;author=A.%20Tefferi&amp;author=JW.%20Vardiman&amp;journal=N%20Eng%20J%20Med&amp;volume=361&amp;pages=1872-1885&amp;publication_year=2009&amp;doi=10.1056%2FNEJMra0902908"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR2">Acquaviva C, Gelsi-Boyer V, Birnbaum D: Myelodysplastic syndromes: lost between two states?. Leukemia. 2010, 24: 1-5. 10.1038/leu.2009.157.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/leu.2009.157"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20068572"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Myelodysplastic%20syndromes%3A%20lost%20between%20two%20states%3F&amp;author=C.%20Acquaviva&amp;author=V.%20Gelsi-Boyer&amp;author=D.%20Birnbaum&amp;journal=Leukemia&amp;volume=24&amp;pages=1-5&amp;publication_year=2010&amp;doi=10.1038%2Fleu.2009.157"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR3">Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Massé A, Kosmider O, Le Couedic JP, Robert F, Alberdi A, Plo I, Dreyfus FJ, Marzac C, Casadevall N, Lacombe C, Romana SP, Dessen P, Soulier J, Viguié F, Fontenay M, Vainchenker W, Bernard OA: Mutation in <em class="EmphasisTypeItalic">TET2</em> in myeloid cancers. N Engl J Med. 2009, 360: 2289-2301. 10.1056/NEJMoa0810069.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1056/NEJMoa0810069"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19474426"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Mutation%20in%20TET2in%20myeloid%20cancers&amp;author=F.%20Delhommeau&amp;author=S.%20Dupont&amp;author=V.%20Della%20Valle&amp;author=C.%20James&amp;author=S.%20Trannoy&amp;author=A.%20Mass%C3%A9&amp;author=O.%20Kosmider&amp;author=JP.%20Le%20Couedic&amp;author=F.%20Robert&amp;author=A.%20Alberdi&amp;author=I.%20Plo&amp;author=FJ.%20Dreyfus&amp;author=C.%20Marzac&amp;author=N.%20Casadevall&amp;author=C.%20Lacombe&amp;author=SP.%20Romana&amp;author=P.%20Dessen&amp;author=J.%20Soulier&amp;author=F.%20Vigui%C3%A9&amp;author=M.%20Fontenay&amp;author=W.%20Vainchenker&amp;author=OA.%20Bernard&amp;journal=N%20Engl%20J%20Med&amp;volume=360&amp;pages=2289-2301&amp;publication_year=2009&amp;doi=10.1056%2FNEJMoa0810069"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR4">Tefferi A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, Patnaik MM, Hanson CA, Pardanani A, Gilliland DG, Levine RL: Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia. 2009, 23: 1343-1345. 10.1038/leu.2009.59.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/leu.2009.59"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19295549"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654626"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Detection%20of%20mutant%20TET2%20in%20myeloid%20malignancies%20other%20than%20myeloproliferative%20neoplasms%3A%20CMML%2C%20MDS%2C%20MDS%2FMPN%20and%20AML&amp;author=A.%20Tefferi&amp;author=KH.%20Lim&amp;author=O.%20Abdel-Wahab&amp;author=TL.%20Lasho&amp;author=J.%20Patel&amp;author=MM.%20Patnaik&amp;author=CA.%20Hanson&amp;author=A.%20Pardanani&amp;author=DG.%20Gilliland&amp;author=RL.%20Levine&amp;journal=Leukemia&amp;volume=23&amp;pages=1343-1345&amp;publication_year=2009&amp;doi=10.1038%2Fleu.2009.59"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR5">Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP: Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood. 2009, 113: 6403-6410. 10.1182/blood-2009-02-205690.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1182/blood-2009-02-205690"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19372255"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710933"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Loss%20of%20heterozygosity%204q24%20and%20TET2%20mutations%20associated%20with%20myelodysplastic%2Fmyeloproliferative%20neoplasms&amp;author=AM.%20Jankowska&amp;author=H.%20Szpurka&amp;author=RV.%20Tiu&amp;author=H.%20Makishima&amp;author=M.%20Afable&amp;author=J.%20Huh&amp;author=CL.%20O%27Keefe&amp;author=R.%20Ganetzky&amp;author=MA.%20McDevitt&amp;author=JP.%20Maciejewski&amp;journal=Blood&amp;volume=113&amp;pages=6403-6410&amp;publication_year=2009&amp;doi=10.1182%2Fblood-2009-02-205690"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR6">Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao JJ, Kilpivaara O, Bhat R, Huberman K, Thomas S, Dolgalev I, Heguy A, Paietta E, Le Beau MM, Beran M, Tallman MS, Ebert BL, Kantarjian HM, Stone RM, Gilliland DG, Crispino JD, Levine RL: Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009, 114: 144-147. 10.1182/blood-2009-03-210039.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1182/blood-2009-03-210039"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19420352"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710942"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Genetic%20characterization%20of%20TET1%2C%20TET2%2C%20and%20TET3%20alterations%20in%20myeloid%20malignancies&amp;author=O.%20Abdel-Wahab&amp;author=A.%20Mullally&amp;author=C.%20Hedvat&amp;author=G.%20Garcia-Manero&amp;author=J.%20Patel&amp;author=M.%20Wadleigh&amp;author=S.%20Malinge&amp;author=JJ.%20Yao&amp;author=O.%20Kilpivaara&amp;author=R.%20Bhat&amp;author=K.%20Huberman&amp;author=S.%20Thomas&amp;author=I.%20Dolgalev&amp;author=A.%20Heguy&amp;author=E.%20Paietta&amp;author=MM.%20Le%20Beau&amp;author=M.%20Beran&amp;author=MS.%20Tallman&amp;author=BL.%20Ebert&amp;author=HM.%20Kantarjian&amp;author=RM.%20Stone&amp;author=DG.%20Gilliland&amp;author=JD.%20Crispino&amp;author=RL.%20Levine&amp;journal=Blood&amp;volume=114&amp;pages=144-147&amp;publication_year=2009&amp;doi=10.1182%2Fblood-2009-03-210039"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR7">Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M, Stevens-Linders E, van Hoogen P, Geurts van Kessel A, Raymakers RAP, Kamping EJ, Verhoef GE, Verburgh E, Hagemeijer A, Vandenberghe P, de Witte T, van der Reijden BA, Janssen JH: Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet. 2009, 41: 838-842. 10.1038/ng.391.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/ng.391"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19483684"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Acquired%20mutations%20in%20TET2%20are%20common%20in%20myelodysplastic%20syndromes&amp;author=SM.%20Langemeijer&amp;author=RP.%20Kuiper&amp;author=M.%20Berends&amp;author=R.%20Knops&amp;author=MG.%20Aslanyan&amp;author=M.%20Massop&amp;author=E.%20Stevens-Linders&amp;author=P.%20van%20Hoogen&amp;author=A.%20Geurts%20van%20Kessel&amp;author=RAP.%20Raymakers&amp;author=EJ.%20Kamping&amp;author=GE.%20Verhoef&amp;author=E.%20Verburgh&amp;author=A.%20Hagemeijer&amp;author=P.%20Vandenberghe&amp;author=T.%20de%20Witte&amp;author=BA.%20van%20der%20Reijden&amp;author=JH.%20Janssen&amp;journal=Nat%20Genet&amp;volume=41&amp;pages=838-842&amp;publication_year=2009&amp;doi=10.1038%2Fng.391"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR8">Mohamedali AM, Smith AE, Gaken J, Lea NC, Mian SA, Westwood NB, Strupp C, Gattermann N, Germing U, Mufti GJ: Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromes. J Clin Oncol. 2009, 27: 4002-4006. 10.1200/JCO.2009.22.6985.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1200/JCO.2009.22.6985"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19528370"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Novel%20TET2%20mutations%20associated%20with%20UPD4q24%20in%20myelodysplastic%20syndromes&amp;author=AM.%20Mohamedali&amp;author=AE.%20Smith&amp;author=J.%20Gaken&amp;author=NC.%20Lea&amp;author=SA.%20Mian&amp;author=NB.%20Westwood&amp;author=C.%20Strupp&amp;author=N.%20Gattermann&amp;author=U.%20Germing&amp;author=GJ.%20Mufti&amp;journal=J%20Clin%20Oncol&amp;volume=27&amp;pages=4002-4006&amp;publication_year=2009&amp;doi=10.1200%2FJCO.2009.22.6985"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR9">Kosmider O, Gelsi-Boyer V, Cheok M, Grabar S, Della-Valle V, Picard F, Viguié F, Quesnel B, Beyne-Rauzy O, Solary E, Vey N, Hunault-Berger M, Fenaux P, Mansat-De Mas V, Delabesse E, Guardiola P, Lacombe C, Vainchenker W, Preudhomme C, Dreyfus F, Bernard OA, Birnbaum D, Fontenay M: TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDS). Blood. 2009, 114: 3285-3291. 10.1182/blood-2009-04-215814.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1182/blood-2009-04-215814"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19666869"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=TET2%20mutation%20is%20an%20independent%20favorable%20prognostic%20factor%20in%20myelodysplastic%20syndromes%20%28MDS%29&amp;author=O.%20Kosmider&amp;author=V.%20Gelsi-Boyer&amp;author=M.%20Cheok&amp;author=S.%20Grabar&amp;author=V.%20Della-Valle&amp;author=F.%20Picard&amp;author=F.%20Vigui%C3%A9&amp;author=B.%20Quesnel&amp;author=O.%20Beyne-Rauzy&amp;author=E.%20Solary&amp;author=N.%20Vey&amp;author=M.%20Hunault-Berger&amp;author=P.%20Fenaux&amp;author=V.%20Mansat-De%20Mas&amp;author=E.%20Delabesse&amp;author=P.%20Guardiola&amp;author=C.%20Lacombe&amp;author=W.%20Vainchenker&amp;author=C.%20Preudhomme&amp;author=F.%20Dreyfus&amp;author=OA.%20Bernard&amp;author=D.%20Birnbaum&amp;author=M.%20Fontenay&amp;journal=Blood&amp;volume=114&amp;pages=3285-3291&amp;publication_year=2009&amp;doi=10.1182%2Fblood-2009-04-215814"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR10">Gelsi-Boyer V, Trouplin V, Adélaïde J, Bonansea J, Cervera N, Carbuccia N, Lagarde A, Prébet T, Nezri M, Sainty D, Olschwang S, Xerri L, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D: Mutations of polycomb-associated gene <em class="EmphasisTypeItalic">ASXL1</em> in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol. 2009, 145: 788-800. 10.1111/j.1365-2141.2009.07697.x.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1111/j.1365-2141.2009.07697.x"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19388938"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Mutations%20of%20polycomb-associated%20gene%20ASXL1in%20myelodysplastic%20syndromes%20and%20chronic%20myelomonocytic%20leukaemia&amp;author=V.%20Gelsi-Boyer&amp;author=V.%20Trouplin&amp;author=J.%20Ad%C3%A9la%C3%AFde&amp;author=J.%20Bonansea&amp;author=N.%20Cervera&amp;author=N.%20Carbuccia&amp;author=A.%20Lagarde&amp;author=T.%20Pr%C3%A9bet&amp;author=M.%20Nezri&amp;author=D.%20Sainty&amp;author=S.%20Olschwang&amp;author=L.%20Xerri&amp;author=M.%20Chaffanet&amp;author=MJ.%20Mozziconacci&amp;author=N.%20Vey&amp;author=D.%20Birnbaum&amp;journal=Br%20J%20Haematol&amp;volume=145&amp;pages=788-800&amp;publication_year=2009&amp;doi=10.1111%2Fj.1365-2141.2009.07697.x"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR11">Makishima H, Cazzolli H, Szpurka H, Dunbar A, Tiu R, Huh J, Muramatsu H, O'Keefe C, Hsi E, Paquette RL, Kojima S, List AF, Sekeres MA, McDevitt MA, Maciejewski JP: Mutations of E3 ligase <em class="EmphasisTypeItalic">Cbl</em> family members constitute a novel common pathogenic lesion in myeloid malignancies. J Clin Oncol. 2009, 27: 6109-6116. 10.1200/JCO.2009.23.7503.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1200/JCO.2009.23.7503"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19901108"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040009"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Mutations%20of%20E3%20ligase%20Cblfamily%20members%20constitute%20a%20novel%20common%20pathogenic%20lesion%20in%20myeloid%20malignancies&amp;author=H.%20Makishima&amp;author=H.%20Cazzolli&amp;author=H.%20Szpurka&amp;author=A.%20Dunbar&amp;author=R.%20Tiu&amp;author=J.%20Huh&amp;author=H.%20Muramatsu&amp;author=C.%20O%27Keefe&amp;author=E.%20Hsi&amp;author=RL.%20Paquette&amp;author=S.%20Kojima&amp;author=AF.%20List&amp;author=MA.%20Sekeres&amp;author=MA.%20McDevitt&amp;author=JP.%20Maciejewski&amp;journal=J%20Clin%20Oncol&amp;volume=27&amp;pages=6109-6116&amp;publication_year=2009&amp;doi=10.1200%2FJCO.2009.23.7503"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR12">Falini B, Bolli N, Liso A, Martelli MP, Mannucci R, Pileri S, Nicoletti N: Altered nucleophosmin transport in acute myeloid leukaemia with mutated <em class="EmphasisTypeItalic">NPM1</em>: molecular basis and clinical implications. Leukemia. 2009, 23: 1731-1743. 10.1038/leu.2009.124.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/leu.2009.124"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19516275"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Altered%20nucleophosmin%20transport%20in%20acute%20myeloid%20leukaemia%20with%20mutated%20NPM1%3A%20molecular%20basis%20and%20clinical%20implications&amp;author=B.%20Falini&amp;author=N.%20Bolli&amp;author=A.%20Liso&amp;author=MP.%20Martelli&amp;author=R.%20Mannucci&amp;author=S.%20Pileri&amp;author=N.%20Nicoletti&amp;journal=Leukemia&amp;volume=23&amp;pages=1731-1743&amp;publication_year=2009&amp;doi=10.1038%2Fleu.2009.124"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR13">Gaidzik V, Döhner K: Prognostic implications of gene mutations in acute myeloid leukemia with normal karyotype. Semin Oncol. 2008, 35: 346-355. 10.1053/j.seminoncol.2008.04.005.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1053/j.seminoncol.2008.04.005"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18692685"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Prognostic%20implications%20of%20gene%20mutations%20in%20acute%20myeloid%20leukemia%20with%20normal%20karyotype&amp;author=V.%20Gaidzik&amp;author=K.%20D%C3%B6hner&amp;journal=Semin%20Oncol&amp;volume=35&amp;pages=346-355&amp;publication_year=2008&amp;doi=10.1053%2Fj.seminoncol.2008.04.005"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR14">Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, Fulton LA, Locke DP, Magrini VJ, Abbott RM, Vickery TL, Reed JS, Robinson JS, Wylie T, Smith SM, Carmichael L, Elred JM, Harris CC, Walker J, Peck JB, Du F, Dukes AF, Sanderson GE, Brummett AM, Clark E, McMichael JF, Meyer RJ, Schindler JK, Pohl CS, Wallis JW, Shi X, Lin L, Schmidt H, Tang Y, Haipek C, Wiechert ME, Ivy JV, Kalicki J, Elliott G, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson MA, Baty J, Heath S, Shannon WD, Nagarajan R, Link DC, Walter MJ, Graubert TA, DiPersio JF, Wilson RK, Ley TJ: Recurrent mutations found by sequencing an acute myeloid leukemia genome. N Eng J Med. 2009, 361: 1058-1066. 10.1056/NEJMoa0903840.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1056/NEJMoa0903840"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Recurrent%20mutations%20found%20by%20sequencing%20an%20acute%20myeloid%20leukemia%20genome&amp;author=ER.%20Mardis&amp;author=L.%20Ding&amp;author=DJ.%20Dooling&amp;author=DE.%20Larson&amp;author=MD.%20McLellan&amp;author=K.%20Chen&amp;author=DC.%20Koboldt&amp;author=RS.%20Fulton&amp;author=KD.%20Delehaunty&amp;author=SD.%20McGrath&amp;author=LA.%20Fulton&amp;author=DP.%20Locke&amp;author=VJ.%20Magrini&amp;author=RM.%20Abbott&amp;author=TL.%20Vickery&amp;author=JS.%20Reed&amp;author=JS.%20Robinson&amp;author=T.%20Wylie&amp;author=SM.%20Smith&amp;author=L.%20Carmichael&amp;author=JM.%20Elred&amp;author=CC.%20Harris&amp;author=J.%20Walker&amp;author=JB.%20Peck&amp;author=F.%20Du&amp;author=AF.%20Dukes&amp;author=GE.%20Sanderson&amp;author=AM.%20Brummett&amp;author=E.%20Clark&amp;author=JF.%20McMichael&amp;author=RJ.%20Meyer&amp;author=JK.%20Schindler&amp;author=CS.%20Pohl&amp;author=JW.%20Wallis&amp;author=X.%20Shi&amp;author=L.%20Lin&amp;author=H.%20Schmidt&amp;author=Y.%20Tang&amp;author=C.%20Haipek&amp;author=ME.%20Wiechert&amp;author=JV.%20Ivy&amp;author=J.%20Kalicki&amp;author=G.%20Elliott&amp;author=RE.%20Ries&amp;author=JE.%20Payton&amp;author=P.%20Westervelt&amp;author=MH.%20Tomasson&amp;author=MA.%20Watson&amp;author=J.%20Baty&amp;author=S.%20Heath&amp;author=WD.%20Shannon&amp;author=R.%20Nagarajan&amp;author=DC.%20Link&amp;author=MJ.%20Walter&amp;author=TA.%20Graubert&amp;author=JF.%20DiPersio&amp;author=RK.%20Wilson&amp;author=TJ.%20Ley&amp;journal=N%20Eng%20J%20Med&amp;volume=361&amp;pages=1058-1066&amp;publication_year=2009&amp;doi=10.1056%2FNEJMoa0903840"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR15">Carbuccia N, Trouplin V, Gelsi-Boyer V, Murati A, Rocquain J, Adélaïde J, Olschwang S, Xerri L, Vey N, Chaffanet M, Birnbaum D, Mozziconacci MJ: Mutual exclusion of <em class="EmphasisTypeItalic">ASXL1</em> and <em class="EmphasisTypeItalic">NPM1</em> mutations in a series of acute myeloid leukemias. Leukemia. 2010, 24: 469-473. 10.1038/leu.2009.218.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/leu.2009.218"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19865112"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Mutual%20exclusion%20of%20ASXL1%20and%20NPM1mutations%20in%20a%20series%20of%20acute%20myeloid%20leukemias&amp;author=N.%20Carbuccia&amp;author=V.%20Trouplin&amp;author=V.%20Gelsi-Boyer&amp;author=A.%20Murati&amp;author=J.%20Rocquain&amp;author=J.%20Ad%C3%A9la%C3%AFde&amp;author=S.%20Olschwang&amp;author=L.%20Xerri&amp;author=N.%20Vey&amp;author=M.%20Chaffanet&amp;author=D.%20Birnbaum&amp;author=MJ.%20Mozziconacci&amp;journal=Leukemia&amp;volume=24&amp;pages=469-473&amp;publication_year=2010&amp;doi=10.1038%2Fleu.2009.218"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR16">Gilliland DG: Molecular genetics of human leukemias: new insights into therapy. Semin Hematol. 2002, 39: 6-11. 10.1053/shem.2002.36921.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1053/shem.2002.36921"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12447846"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Molecular%20genetics%20of%20human%20leukemias%3A%20new%20insights%20into%20therapy&amp;author=DG.%20Gilliland&amp;journal=Semin%20Hematol&amp;volume=39&amp;pages=6-11&amp;publication_year=2002&amp;doi=10.1053%2Fshem.2002.36921"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR17">Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009, 114: 937-951. 10.1182/blood-2009-03-209262.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1182/blood-2009-03-209262"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19357394"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=The%202008%20revision%20of%20the%20World%20Health%20Organization%20%28WHO%29%20classification%20of%20myeloid%20neoplasms%20and%20acute%20leukemia%3A%20rationale%20and%20important%20changes&amp;author=JW.%20Vardiman&amp;author=J.%20Thiele&amp;author=DA.%20Arber&amp;author=RD.%20Brunning&amp;author=MJ.%20Borowitz&amp;author=A.%20Porwit&amp;author=NL.%20Harris&amp;author=MM.%20Le%20Beau&amp;author=E.%20Hellstr%C3%B6m-Lindberg&amp;author=A.%20Tefferi&amp;author=CD.%20Bloomfield&amp;journal=Blood&amp;volume=114&amp;pages=937-951&amp;publication_year=2009&amp;doi=10.1182%2Fblood-2009-03-209262"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR18">Murati A, Gervais C, Carbuccia N, Finetti P, Cervera N, Adélaïde J, Struski S, Lippert E, Mugneret F, Tigaud I, Penther D, Bastard C, Poppe B, Speleman F, Baranger L, Luquet I, Cornillet-Lefebvre P, Nadal N, Nguyen-Khac F, Pérot C, Olschwang S, Bertucci F, Chaffanet M, Lessard M, Mozziconacci MJ, Birnbaum D: Genomic profiling of acute myelomonocytic leukemia: alteration of the <em class="EmphasisTypeItalic">MYB</em> locusin <em class="EmphasisTypeItalic">MYST3</em>-linked cases. Leukemia. 2009, 23: 85-94. 10.1038/leu.2008.257.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/leu.2008.257"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18818702"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Genomic%20profiling%20of%20acute%20myelomonocytic%20leukemia%3A%20alteration%20of%20the%20MYB%20locusin%20MYST3-linked%20cases&amp;author=A.%20Murati&amp;author=C.%20Gervais&amp;author=N.%20Carbuccia&amp;author=P.%20Finetti&amp;author=N.%20Cervera&amp;author=J.%20Ad%C3%A9la%C3%AFde&amp;author=S.%20Struski&amp;author=E.%20Lippert&amp;author=F.%20Mugneret&amp;author=I.%20Tigaud&amp;author=D.%20Penther&amp;author=C.%20Bastard&amp;author=B.%20Poppe&amp;author=F.%20Speleman&amp;author=L.%20Baranger&amp;author=I.%20Luquet&amp;author=P.%20Cornillet-Lefebvre&amp;author=N.%20Nadal&amp;author=F.%20Nguyen-Khac&amp;author=C.%20P%C3%A9rot&amp;author=S.%20Olschwang&amp;author=F.%20Bertucci&amp;author=M.%20Chaffanet&amp;author=M.%20Lessard&amp;author=MJ.%20Mozziconacci&amp;author=D.%20Birnbaum&amp;journal=Leukemia&amp;volume=23&amp;pages=85-94&amp;publication_year=2009&amp;doi=10.1038%2Fleu.2008.257"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR19">Gelsi-Boyer V, Trouplin V, Adélaïde J, Aceto N, Remy V, Pinson S, Houdayer C, Arnoulet C, Sainty D, Bentires-Alj M, Olschwang S, Vey N, Mozziconacci MJ, Birnbaum D, Chaffanet M: Genome profiling of chronic myelomonocytic leukemia: frequent alterations of <em class="EmphasisTypeItalic">RAS</em> and <em class="EmphasisTypeItalic">RUNX1</em> genes. BMC Cancer. 2008, 8: 299-314. 10.1186/1471-2407-8-299.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1186/1471-2407-8-299"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18925961"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588460"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Genome%20profiling%20of%20chronic%20myelomonocytic%20leukemia%3A%20frequent%20alterations%20of%20RAS%20and%20RUNX1genes&amp;author=V.%20Gelsi-Boyer&amp;author=V.%20Trouplin&amp;author=J.%20Ad%C3%A9la%C3%AFde&amp;author=N.%20Aceto&amp;author=V.%20Remy&amp;author=S.%20Pinson&amp;author=C.%20Houdayer&amp;author=C.%20Arnoulet&amp;author=D.%20Sainty&amp;author=M.%20Bentires-Alj&amp;author=S.%20Olschwang&amp;author=N.%20Vey&amp;author=MJ.%20Mozziconacci&amp;author=D.%20Birnbaum&amp;author=M.%20Chaffanet&amp;journal=BMC%20Cancer&amp;volume=8&amp;pages=299-314&amp;publication_year=2008&amp;doi=10.1186%2F1471-2407-8-299"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR20">Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamasaki S, Tamura A, Honda H, Sakata-Yanagimoto M, Kumano K, Oda H, Yamagata T, Takita J, Gotoh N, Nakazaki K, Kawamata N, Onodera M, Nobuyoshi M, Hayashi Y, Harada H, Kurokawa M, Chiba S, Mori H, Ozawa K, Omine M, Hirai H, Nakauchi H, Koeffler HP, Ogawa S: Gain-of-function of mutated CBL tumour suppressor in myeloid neoplasms. Nature. 2009, 460: 904-908. 10.1038/nature08240.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/nature08240"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19620960"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Gain-of-function%20of%20mutated%20CBL%20tumour%20suppressor%20in%20myeloid%20neoplasms&amp;author=M.%20Sanada&amp;author=T.%20Suzuki&amp;author=LY.%20Shih&amp;author=M.%20Otsu&amp;author=M.%20Kato&amp;author=S.%20Yamasaki&amp;author=A.%20Tamura&amp;author=H.%20Honda&amp;author=M.%20Sakata-Yanagimoto&amp;author=K.%20Kumano&amp;author=H.%20Oda&amp;author=T.%20Yamagata&amp;author=J.%20Takita&amp;author=N.%20Gotoh&amp;author=K.%20Nakazaki&amp;author=N.%20Kawamata&amp;author=M.%20Onodera&amp;author=M.%20Nobuyoshi&amp;author=Y.%20Hayashi&amp;author=H.%20Harada&amp;author=M.%20Kurokawa&amp;author=S.%20Chiba&amp;author=H.%20Mori&amp;author=K.%20Ozawa&amp;author=M.%20Omine&amp;author=H.%20Hirai&amp;author=H.%20Nakauchi&amp;author=HP.%20Koeffler&amp;author=S.%20Ogawa&amp;journal=Nature&amp;volume=460&amp;pages=904-908&amp;publication_year=2009&amp;doi=10.1038%2Fnature08240"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR21">Renneville A, Boissel N, Zurawski V, Llopis L, Biggio V, Nibourel O, Philippe N, Thomas X, Dombret H, Preudhomme C: Wilms tumor gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association. Cancer. 2009, 115: 3719-3727. 10.1002/cncr.24442.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1002/cncr.24442"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19536888"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Wilms%20tumor%20gene%20mutations%20are%20associated%20with%20a%20higher%20risk%20of%20recurrence%20in%20young%20adults%20with%20acute%20myeloid%20leukemia%3A%20a%20study%20from%20the%20Acute%20Leukemia%20French%20Association&amp;author=A.%20Renneville&amp;author=N.%20Boissel&amp;author=V.%20Zurawski&amp;author=L.%20Llopis&amp;author=V.%20Biggio&amp;author=O.%20Nibourel&amp;author=N.%20Philippe&amp;author=X.%20Thomas&amp;author=H.%20Dombret&amp;author=C.%20Preudhomme&amp;journal=Cancer&amp;volume=115&amp;pages=3719-3727&amp;publication_year=2009&amp;doi=10.1002%2Fcncr.24442"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR22">Virappane P, Gale R, Hills R, Kakkas I, Summers K, Stevens J, Allen C, Green C, Quentmeier H, Drexler H, Burnett A, Linch D, Bonnet D, Lister TA, Fitzgibbon J: Mutation of the Wilm's tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukaemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2008, 26: 5429-5435. 10.1200/JCO.2008.16.0333.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1200/JCO.2008.16.0333"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18591546"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Mutation%20of%20the%20Wilm%27s%20tumor%201%20gene%20is%20a%20poor%20prognostic%20factor%20associated%20with%20chemotherapy%20resistance%20in%20normal%20karyotype%20acute%20myeloid%20leukaemia%3A%20the%20United%20Kingdom%20Medical%20Research%20Council%20Adult%20Leukaemia%20Working%20Party&amp;author=P.%20Virappane&amp;author=R.%20Gale&amp;author=R.%20Hills&amp;author=I.%20Kakkas&amp;author=K.%20Summers&amp;author=J.%20Stevens&amp;author=C.%20Allen&amp;author=C.%20Green&amp;author=H.%20Quentmeier&amp;author=H.%20Drexler&amp;author=A.%20Burnett&amp;author=D.%20Linch&amp;author=D.%20Bonnet&amp;author=TA.%20Lister&amp;author=J.%20Fitzgibbon&amp;journal=J%20Clin%20Oncol&amp;volume=26&amp;pages=5429-5435&amp;publication_year=2008&amp;doi=10.1200%2FJCO.2008.16.0333"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR23">Green A, Beer P: Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. New Engl J Med. 2010, 362: 369-370. 10.1056/NEJMc0910063.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1056/NEJMc0910063"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20107228"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Somatic%20mutations%20of%20IDH1%20and%20IDH2%20in%20the%20leukemic%20transformation%20of%20myeloproliferative%20neoplasms&amp;author=A.%20Green&amp;author=P.%20Beer&amp;journal=New%20Engl%20J%20Med&amp;volume=362&amp;pages=369-370&amp;publication_year=2010&amp;doi=10.1056%2FNEJMc0910063"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR24">Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett B, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, Rabinowitz JD, Carroll M, Su S, Sharp KA, Levine RL, Thompson CB: The common features of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydoxyglutarate. Cancer Cell. 2010, 17: 1-10. 10.1016/j.ccr.2010.01.020.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1016/j.ccr.2010.01.020"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=The%20common%20features%20of%20leukemia-associated%20IDH1%20and%20IDH2%20mutations%20is%20a%20neomorphic%20enzyme%20activity%20converting%20%CE%B1-ketoglutarate%20to%202-hydoxyglutarate&amp;author=PS.%20Ward&amp;author=J.%20Patel&amp;author=DR.%20Wise&amp;author=O.%20Abdel-Wahab&amp;author=B.%20Bennett&amp;author=HA.%20Coller&amp;author=JR.%20Cross&amp;author=VR.%20Fantin&amp;author=CV.%20Hedvat&amp;author=AE.%20Perl&amp;author=JD.%20Rabinowitz&amp;author=M.%20Carroll&amp;author=S.%20Su&amp;author=KA.%20Sharp&amp;author=RL.%20Levine&amp;author=CB.%20Thompson&amp;journal=Cancer%20Cell&amp;volume=17&amp;pages=1-10&amp;publication_year=2010&amp;doi=10.1016%2Fj.ccr.2010.01.020"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR25">Boultwood J, Perry J, Pellagatti A, Fernandez-Mercado M, Fernandez-Santamaria C, Calasanz MJ, Larrayoz MJ, Garcia-Delgado M, Giagounidis A, Malcovati L, Della Porta MG, Jädersten M, Killick S, Hellström-Lindbergh E, Cazzola M, Wainscoat JS: Frequent mutations of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia. 2010, 24: 1062-1065. 10.1038/leu.2010.20.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/leu.2010.20"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20182461"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Frequent%20mutations%20of%20the%20polycomb-associated%20gene%20ASXL1%20in%20the%20myelodysplastic%20syndromes%20and%20in%20acute%20myeloid%20leukemia&amp;author=J.%20Boultwood&amp;author=J.%20Perry&amp;author=A.%20Pellagatti&amp;author=M.%20Fernandez-Mercado&amp;author=C.%20Fernandez-Santamaria&amp;author=MJ.%20Calasanz&amp;author=MJ.%20Larrayoz&amp;author=M.%20Garcia-Delgado&amp;author=A.%20Giagounidis&amp;author=L.%20Malcovati&amp;author=MG.%20Della%20Porta&amp;author=M.%20J%C3%A4dersten&amp;author=S.%20Killick&amp;author=E.%20Hellstr%C3%B6m-Lindbergh&amp;author=M.%20Cazzola&amp;author=JS.%20Wainscoat&amp;journal=Leukemia&amp;volume=24&amp;pages=1062-1065&amp;publication_year=2010&amp;doi=10.1038%2Fleu.2010.20"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR26">Lavagna-Sévenier C, Marchetto S, Birnbaum D, Rosnet O: FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates. Leukemia. 1998, 12: 301-310. 10.1038/sj.leu.2400921.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/sj.leu.2400921"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9529123"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=FLT3%20signaling%20in%20hematopoietic%20cells%20involves%20CBL%2C%20SHC%20and%20an%20unknown%20P115%20as%20prominent%20tyrosine-phosphorylated%20substrates&amp;author=C.%20Lavagna-S%C3%A9venier&amp;author=S.%20Marchetto&amp;author=D.%20Birnbaum&amp;author=O.%20Rosnet&amp;journal=Leukemia&amp;volume=12&amp;pages=301-310&amp;publication_year=1998&amp;doi=10.1038%2Fsj.leu.2400921"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR27">Dunbar AJ, Gondek LP, O'Keefe CL, Makishima H, Rataul MS, Szpurka H, Sekeres MA, Wang XF, McDevitt MA, Maciejewski JP: 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. Cancer Res. 2008, 68: 10340-10357. 10.1158/0008-5472.CAN-08-2754.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1158/0008-5472.CAN-08-2754"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=250K%20single%20nucleotide%20polymorphism%20array%20karyotyping%20identifies%20acquired%20uniparental%20disomy%20and%20homozygous%20mutations%2C%20including%20novel%20missense%20substitutions%20of%20c-Cbl%2C%20in%20myeloid%20malignancies&amp;author=AJ.%20Dunbar&amp;author=LP.%20Gondek&amp;author=CL.%20O%27Keefe&amp;author=H.%20Makishima&amp;author=MS.%20Rataul&amp;author=H.%20Szpurka&amp;author=MA.%20Sekeres&amp;author=XF.%20Wang&amp;author=MA.%20McDevitt&amp;author=JP.%20Maciejewski&amp;journal=Cancer%20Res&amp;volume=68&amp;pages=10340-10357&amp;publication_year=2008&amp;doi=10.1158%2F0008-5472.CAN-08-2754"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR28">Pollard PJ, Ratcliffe PJ: Puzzling patterns of predisposition. Science. 2009, 324: 192-194. 10.1126/science.1173362.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1126/science.1173362"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19359573"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Puzzling%20patterns%20of%20predisposition&amp;author=PJ.%20Pollard&amp;author=PJ.%20Ratcliffe&amp;journal=Science&amp;volume=324&amp;pages=192-194&amp;publication_year=2009&amp;doi=10.1126%2Fscience.1173362"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR29">Wagner KD, Wagner N, Wellman S, Schley G, Bondke A, Theres H, Scholz H: Oxygen-regulated expression of the Wilm's tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J. 2003, 17: 1364-1366.<span class="Occurrences"><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12738801"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Oxygen-regulated%20expression%20of%20the%20Wilm%27s%20tumor%20suppressor%20Wt1%20involves%20hypoxia-inducible%20factor-1%20%28HIF-1%29&amp;author=KD.%20Wagner&amp;author=N.%20Wagner&amp;author=S.%20Wellman&amp;author=G.%20Schley&amp;author=A.%20Bondke&amp;author=H.%20Theres&amp;author=H.%20Scholz&amp;journal=FASEB%20J&amp;volume=17&amp;pages=1364-1366&amp;publication_year=2003"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR30">Couronné L, Lippert E, Andrieux J, Kosmider O, Radford-Weiss I, Penther D, et al: Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias. Leukemia. 2010, 24: 201-203. 10.1038/leu.2009.169.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/leu.2009.169"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19710701"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Analyses%20of%20TET2%20mutations%20in%20post-myeloproliferative%20neoplasm%20acute%20myeloid%20leukemias&amp;author=L.%20Couronn%C3%A9&amp;author=E.%20Lippert&amp;author=J.%20Andrieux&amp;author=O.%20Kosmider&amp;author=I.%20Radford-Weiss&amp;author=D.%20Penther&amp;journal=Leukemia&amp;volume=24&amp;pages=201-203&amp;publication_year=2010&amp;doi=10.1038%2Fleu.2009.169"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR31">Bernard F, Gelsi-Boyer V, Murati A, Giraudier S, Trouplin V, Adélaïde J, Rey J, Olschwang S, Vainchenker W, Chaffanet M, Vey N, Mozziconacci MJ, Birnbaum D: Alterations of <em class="EmphasisTypeItalic">NFIA</em> in chronic malignant myeloid diseases. Leukemia. 2009, 23: 583-585. 10.1038/leu.2008.228.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/leu.2008.228"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18754024"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Alterations%20of%20NFIAin%20chronic%20malignant%20myeloid%20diseases&amp;author=F.%20Bernard&amp;author=V.%20Gelsi-Boyer&amp;author=A.%20Murati&amp;author=S.%20Giraudier&amp;author=V.%20Trouplin&amp;author=J.%20Ad%C3%A9la%C3%AFde&amp;author=J.%20Rey&amp;author=S.%20Olschwang&amp;author=W.%20Vainchenker&amp;author=M.%20Chaffanet&amp;author=N.%20Vey&amp;author=MJ.%20Mozziconacci&amp;author=D.%20Birnbaum&amp;journal=Leukemia&amp;volume=23&amp;pages=583-585&amp;publication_year=2009&amp;doi=10.1038%2Fleu.2008.228"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR32">van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, Edkins S, Hardy C, O'Meara S, Teague J, Butler A, Hinton J, Latimer C, Andrews J, Barthorpe S, Beare D, Buck G, Campbell PJ, Cole J, Forbes S, Jia M, Jones D, Kok CY, Leroy C, Lin ML, McBride DJ, Maddison M, Maquire S, McLay K, Menzies A, Mironenko T, Mulderrig L, Mudie L, Pleasance E, Shepherd R, Smith R, Stebbings L, Stephens P, Tang G, Tarpey PS, Turner R, Turrell K, Varian J, West S, Widaa S, Wray P, Collins VP, Ichimura K, Law S, Wong J, Yuen ST, Leung SY, Tonon G, DePinho RA, Tai YT, Anderson KC, Kahnoski RJ, Massie A, Khoo SK, Teh BT, Stratton MR, Futreal PA: Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet. 2009, 41: 521-523. 10.1038/ng.349.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/ng.349"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19330029"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873835"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Somatic%20mutations%20of%20the%20histone%20H3K27%20demethylase%20gene%20UTX%20in%20human%20cancer&amp;author=G.%20van%20Haaften&amp;author=GL.%20Dalgliesh&amp;author=H.%20Davies&amp;author=L.%20Chen&amp;author=G.%20Bignell&amp;author=C.%20Greenman&amp;author=S.%20Edkins&amp;author=C.%20Hardy&amp;author=S.%20O%27Meara&amp;author=J.%20Teague&amp;author=A.%20Butler&amp;author=J.%20Hinton&amp;author=C.%20Latimer&amp;author=J.%20Andrews&amp;author=S.%20Barthorpe&amp;author=D.%20Beare&amp;author=G.%20Buck&amp;author=PJ.%20Campbell&amp;author=J.%20Cole&amp;author=S.%20Forbes&amp;author=M.%20Jia&amp;author=D.%20Jones&amp;author=CY.%20Kok&amp;author=C.%20Leroy&amp;author=ML.%20Lin&amp;author=DJ.%20McBride&amp;author=M.%20Maddison&amp;author=S.%20Maquire&amp;author=K.%20McLay&amp;author=A.%20Menzies&amp;author=T.%20Mironenko&amp;author=L.%20Mulderrig&amp;author=L.%20Mudie&amp;author=E.%20Pleasance&amp;author=R.%20Shepherd&amp;author=R.%20Smith&amp;author=L.%20Stebbings&amp;author=P.%20Stephens&amp;author=G.%20Tang&amp;author=PS.%20Tarpey&amp;author=R.%20Turner&amp;author=K.%20Turrell&amp;author=J.%20Varian&amp;author=S.%20West&amp;author=S.%20Widaa&amp;author=P.%20Wray&amp;author=VP.%20Collins&amp;author=K.%20Ichimura&amp;author=S.%20Law&amp;author=J.%20Wong&amp;author=ST.%20Yuen&amp;author=SY.%20Leung&amp;author=G.%20Tonon&amp;author=RA.%20DePinho&amp;author=YT.%20Tai&amp;author=KC.%20Anderson&amp;author=RJ.%20Kahnoski&amp;author=A.%20Massie&amp;author=SK.%20Khoo&amp;author=BT.%20Teh&amp;author=MR.%20Stratton&amp;author=PA.%20Futreal&amp;journal=Nat%20Genet&amp;volume=41&amp;pages=521-523&amp;publication_year=2009&amp;doi=10.1038%2Fng.349"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR33">Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV, Waghorn K, Zoi K, Ross FM, Reiter A, Hochhaus A, Drexler HG, Duncombe A, Cervantes F, Oscier D, Boultwood J, Grand FH, Cross NCP: Inactivating mutations of the histone methyltransferase gene <em class="EmphasisTypeItalic">EZH2</em>in myeloid disorders. Nat Genet. 2010, <span class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Inactivating%20mutations%20of%20the%20histone%20methyltransferase%20gene%20EZH2in%20myeloid%20disorders&amp;author=T.%20Ernst&amp;author=AJ.%20Chase&amp;author=J.%20Score&amp;author=CE.%20Hidalgo-Curtis&amp;author=C.%20Bryant&amp;author=AV.%20Jones&amp;author=K.%20Waghorn&amp;author=K.%20Zoi&amp;author=FM.%20Ross&amp;author=A.%20Reiter&amp;author=A.%20Hochhaus&amp;author=HG.%20Drexler&amp;author=A.%20Duncombe&amp;author=F.%20Cervantes&amp;author=D.%20Oscier&amp;author=J.%20Boultwood&amp;author=FH.%20Grand&amp;author=NCP.%20Cross&amp;publication_year=2010"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR34">Nikoloski G, Langemeijer SMC, Kuiper RP, Knops R, Massop M, Tönnissen ERLTM, van der Heijden A, Scheele TN, Vandenberghe P, de Witte T, van der Reijden BA, Jansen JH: Somatic mutations of the histone methyltransferase gene <em class="EmphasisTypeItalic">EZH2</em>in myelodysplastic syndromes. Nat Genet. 2010, <span class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Somatic%20mutations%20of%20the%20histone%20methyltransferase%20gene%20EZH2in%20myelodysplastic%20syndromes&amp;author=G.%20Nikoloski&amp;author=SMC.%20Langemeijer&amp;author=RP.%20Kuiper&amp;author=R.%20Knops&amp;author=M.%20Massop&amp;author=ERLTM.%20T%C3%B6nnissen&amp;author=A.%20van%20der%20Heijden&amp;author=TN.%20Scheele&amp;author=P.%20Vandenberghe&amp;author=T.%20de%20Witte&amp;author=BA.%20van%20der%20Reijden&amp;author=JH.%20Jansen&amp;publication_year=2010"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR35">Ding Y, Harada Y, Imagawa J, Kimura A, Harada H: AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms. Blood. 2009, 114: 5201-5205. 10.1182/blood-2009-06-223982.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1182/blood-2009-06-223982"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19850737"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=AML1%2FRUNX1%20point%20mutation%20possibly%20promotes%20leukemic%20transformation%20in%20myeloproliferative%20neoplasms&amp;author=Y.%20Ding&amp;author=Y.%20Harada&amp;author=J.%20Imagawa&amp;author=A.%20Kimura&amp;author=H.%20Harada&amp;journal=Blood&amp;volume=114&amp;pages=5201-5205&amp;publication_year=2009&amp;doi=10.1182%2Fblood-2009-06-223982"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR36">Abdel-Wahab O, Mansouri T, Patel J, Harris K, Yao J, Hedvat C, Hedvat C, Heguy A, Bueso-Ramos C, Kantarjian H, Levine RL, Verstovsek S: Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias. Cancer Res. 2010, 70: 447-452. 10.1158/0008-5472.CAN-09-3783.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1158/0008-5472.CAN-09-3783"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20068184"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947340"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Genetic%20analysis%20of%20transforming%20events%20that%20convert%20chronic%20myeloproliferative%20neoplasms%20to%20leukemias&amp;author=O.%20Abdel-Wahab&amp;author=T.%20Mansouri&amp;author=J.%20Patel&amp;author=K.%20Harris&amp;author=J.%20Yao&amp;author=C.%20Hedvat&amp;author=C.%20Hedvat&amp;author=A.%20Heguy&amp;author=C.%20Bueso-Ramos&amp;author=H.%20Kantarjian&amp;author=RL.%20Levine&amp;author=S.%20Verstovsek&amp;journal=Cancer%20Res&amp;volume=70&amp;pages=447-452&amp;publication_year=2010&amp;doi=10.1158%2F0008-5472.CAN-09-3783"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR37">Dang L, White DW, Gross S, Bennett BD, Bittinger MAA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009, 462: 739-744. 10.1038/nature08617.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/nature08617"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19935646"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818760"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Cancer-associated%20IDH1%20mutations%20produce%202-hydroxyglutarate&amp;author=L.%20Dang&amp;author=DW.%20White&amp;author=S.%20Gross&amp;author=BD.%20Bennett&amp;author=MAA.%20Bittinger&amp;author=EM.%20Driggers&amp;author=VR.%20Fantin&amp;author=HG.%20Jang&amp;author=S.%20Jin&amp;author=MC.%20Keenan&amp;author=KM.%20Marks&amp;author=RM.%20Prins&amp;author=PS.%20Ward&amp;author=KE.%20Yen&amp;author=LM.%20Liau&amp;author=JD.%20Rabinowitz&amp;author=LC.%20Cantley&amp;author=CB.%20Thompson&amp;author=MG.%20Vander%20Heiden&amp;author=SM.%20Su&amp;journal=Nature&amp;volume=462&amp;pages=739-744&amp;publication_year=2009&amp;doi=10.1038%2Fnature08617"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR38">Grisendi S, Mecucci C, Falini B, Pandolfi PP: Nucleophosmin and cancer. Nat Rev Cancer. 2006, 494: 493-505. 10.1038/nrc1885.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1038/nrc1885"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Nucleophosmin%20and%20cancer&amp;author=S.%20Grisendi&amp;author=C.%20Mecucci&amp;author=B.%20Falini&amp;author=PP.%20Pandolfi&amp;journal=Nat%20Rev%20Cancer&amp;volume=494&amp;pages=493-505&amp;publication_year=2006&amp;doi=10.1038%2Fnrc1885"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR39">Fisher CL, Pineault N, Brookes C, Helgason CD, Ohta H, Bodner C, Hess JL, Humphries RK, Brock HW: Loss-of-function <em class="EmphasisTypeItalic">Additional sex coombs-like 1</em> mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia. Blood. 2010, 115: 38-46. 10.1182/blood-2009-07-230698.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" href="https://doi.org/10.1182/blood-2009-07-230698"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19861679"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803690"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" href="http://scholar.google.com/scholar_lookup?title=Loss-of-function%20Additional%20sex%20coombs-like%201mutations%20disrupt%20hematopoiesis%20but%20do%20not%20cause%20severe%20myelodysplasia%20or%20leukemia&amp;author=CL.%20Fisher&amp;author=N.%20Pineault&amp;author=C.%20Brookes&amp;author=CD.%20Helgason&amp;author=H.%20Ohta&amp;author=C.%20Bodner&amp;author=JL.%20Hess&amp;author=RK.%20Humphries&amp;author=HW.%20Brock&amp;journal=Blood&amp;volume=115&amp;pages=38-46&amp;publication_year=2010&amp;doi=10.1182%2Fblood-2009-07-230698"><span><span>Google Scholar</span></span></a></span></span></cite></li><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="BibSection" id="BSec1"><h3 xmlns="" class="Heading">Pre-publication history</h3><ol class="BibliographyWrapper"><li xmlns="" class="Citation"><cite class="CitationContent" id="CR40">The pre-publication history for this paper can be accessed here:<span xmlns="http://www.w3.org/1999/xhtml" class="ExternalRef"><a href="http://www.biomedcentral.com/1471-2407/10/401/prepub"><span class="RefSource">http://www.biomedcentral.com/1471-2407/10/401/prepub</span></a></span>
<span class="Occurrences"></span></cite></li></ol></div></ol></div></section><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1" id="CopyrightMessage"><h2 class="Heading js-ToggleCollapseSection">Copyright</h2><div class="js-CollapseSection"><div xmlns="http://www.w3.org/1999/xhtml" class="ArticleCopyright">©&nbsp;Rocquain et al; licensee BioMed Central Ltd.&nbsp;2010<div class="CopyrightComment">
                <p xmlns="" class="SimplePara">This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="ExternalRef"><a href="http://creativecommons.org/licenses/by/2.0"><span class="RefSource">http://creativecommons.org/licenses/by/2.0</span></a></span>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
              </div></div></div></section></div>
                            


                        </div>
                    </div>
                    <div class="layout__sidebar-right" id="main-sidebar">
                        
                        <div class="block">
                            <aside role="complementary">
                                <div class="SideBox">
                                    
    <p class="SideBox_action">
        <a class="SideBox_pdf" id="articlePdf" target="_blank" href="/track/pdf/10.1186/1471-2407-10-401?site&#x3D;bmccancer.biomedcentral.com" data-track-event="click" data-event-category="PDF Download"
           data-event-action="Click download article PDF"
           data-event-label="10.1186/1471-2407-10-401">Download PDF</a>
    </p>

                                    
                                    
    <h3 class="export-citations-button" data-toggle="collapse" data-target="js-exportCitations">Export citations</h3>
    <div id="js-exportCitations" class="export-citations-content panel">
        <div class="panel__section">
            <h4 class="panel__title">Citations & References</h4>
            <ul class="ListDownload" id="articleReferences">
                <li><a data-track-event="click" data-event-category="Article Page" data-event-action="Download Papers, Zotero, Reference Manager, RefWorks citations and references"
                       data-event-label="10.1186/1471-2407-10-401"
                       href="http://citation-needed.springer.com/v2/references/10.1186/1471-2407-10-401?format=refman&flavour=full">Papers, Zotero, Reference Manager, RefWorks <span>(.RIS)</span></a>
                </li>
                <li><a data-track-event="click" data-event-category="Article Page" data-event-action="Download EndNote citations and references" data-event-label="10.1186/1471-2407-10-401"
                       href="http://citation-needed.springer.com/v2/references/10.1186/1471-2407-10-401?format=endnote&flavour=full">EndNote <span>(.ENW)</span></a></li>
                <li><a data-track-event="click" data-event-category="Article Page" data-event-action="Download Mendeley, JabRef citations and references" data-event-label="10.1186/1471-2407-10-401"
                       href="http://citation-needed.springer.com/v2/references/10.1186/1471-2407-10-401?format=bibtex&flavour=full">Mendeley, JabRef <span>(.BIB)</span></a></li>
            </ul>
        </div>
        <div class="panel__section">
            <h4 class="panel__title">Article citation</h4>
            <ul class="ListDownload">
                <li><a data-track-event="click" data-event-category="Article Page" data-event-action="Download Papers, Zotero, Reference Manager, RefWorks article citations" data-event-label="10.1186/1471-2407-10-401"
                       href="http://citation-needed.springer.com/v2/references/10.1186/1471-2407-10-401?format=refman&flavour=citation">Papers, Zotero, Reference Manager, RefWorks <span>(.RIS)</span></a></li>
                <li><a data-track-event="click" data-event-category="Article Page" data-event-action="Download EndNote article citations" data-event-label="10.1186/1471-2407-10-401"
                       href="http://citation-needed.springer.com/v2/references/10.1186/1471-2407-10-401?format=endnote&flavour=citation">EndNote <span>(.ENW)</span></a></li>
                <li><a data-track-event="click" data-event-category="Article Page" data-event-action="Download Mendeley, JabRef article citations" data-event-label="10.1186/1471-2407-10-401"
                       href="http://citation-needed.springer.com/v2/references/10.1186/1471-2407-10-401?format=bibtex&flavour=citation">Mendeley, JabRef <span>(.BIB)</span></a></li>
            </ul>
        </div>
        <div class="panel__section">
            <h4 class="panel__title">References</h4>
            <ul class="ListDownload">
                <li><a data-track-event="click" data-event-category="Article Page" data-event-action="Download Papers, Zotero, Reference Manager, RefWorks references" data-event-label="10.1186/1471-2407-10-401"
                       href="http://citation-needed.springer.com/v2/references/10.1186/1471-2407-10-401?format=refman&flavour=references">Papers, Zotero, Reference Manager, RefWorks <span>(.RIS)</span></a>
                </li>
                <li><a data-track-event="click" data-event-category="Article Page" data-event-action="Download EndNote references" data-event-label="10.1186/1471-2407-10-401"
                       href="http://citation-needed.springer.com/v2/references/10.1186/1471-2407-10-401?format=endnote&flavour=references">EndNote <span>(.ENW)</span></a></li>
                <li><a data-track-event="click" data-event-category="Article Page" data-event-action="Download Mendeley, JabRef references" data-event-label="10.1186/1471-2407-10-401"
                       href="http://citation-needed.springer.com/v2/references/10.1186/1471-2407-10-401?format=bibtex&flavour=references">Mendeley, JabRef <span>(.BIB)</span></a></li>
            </ul>
        </div>
    </div>

                                </div>
                                <div class="SideBox">
                                    <nav xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="ArticleNavigation" class="table-of-contents" aria-label="table of contents"><div class="table-of-contents__content" data-sticky="toc"><h3 class="table-of-contents__title is-open" data-toggle="collapse" data-target="tocMenu" data-event-category="Table of Contents" data-track-event="click" data-event-action="Toggle ToC" data-event-label="Toggle" data-toggle-disable-clickoff="true" aria-expanded="true">Table of Contents</h3><ul class="table-of-contents__menu is-open" role="menu" id="tocMenu" aria-expanded="true"><li role="menuitem" class="table-of-contents__item"><a class="table-of-contents__link" href="#Abs1" data-event-category="Table of Contents" data-track-event="click" data-event-action="Link Clicked" data-event-label="Abstract">Abstract</a></li><li role="menuitem" class="table-of-contents__item"><a class="table-of-contents__link" href="#Sec1" data-event-category="Table of Contents" data-track-event="click" data-event-action="Link Clicked" data-event-label="Background">Background</a></li><li role="menuitem" class="table-of-contents__item"><a class="table-of-contents__link" href="#Sec2" data-event-category="Table of Contents" data-track-event="click" data-event-action="Link Clicked" data-event-label="Methods">Methods</a></li><li role="menuitem" class="table-of-contents__item"><a class="table-of-contents__link" href="#Sec5" data-event-category="Table of Contents" data-track-event="click" data-event-action="Link Clicked" data-event-label="Results">Results</a></li><li role="menuitem" class="table-of-contents__item"><a class="table-of-contents__link" href="#Sec10" data-event-category="Table of Contents" data-track-event="click" data-event-action="Link Clicked" data-event-label="Discussion">Discussion</a></li><li role="menuitem" class="table-of-contents__item"><a class="table-of-contents__link" href="#Sec15" data-event-category="Table of Contents" data-track-event="click" data-event-action="Link Clicked" data-event-label="Conclusion">Conclusion</a></li><li role="menuitem" class="table-of-contents__item"><a class="table-of-contents__link" href="#Declarations" data-event-category="Table of Contents" data-track-event="click" data-event-action="Link Clicked" data-event-label="Declarations">
                        Declarations
                      </a></li><li role="menuitem" class="table-of-contents__item"><a class="table-of-contents__link" href="#Bib1" data-event-category="Table of Contents" data-track-event="click" data-event-action="Link Clicked" data-event-label="References">References</a></li><li role="menuitem" class="table-of-contents__item is-hidden"><a class="table-of-contents__link" href="#comments" data-event-category="Table of Contents" data-track-event="click" data-event-action="Link Clicked" data-event-label="Comments">Comments</a></li></ul></div></nav>
                                </div>
                                <div class="SideBox">
                                    <h3 class="SideBox_title">Metrics</h3>
                                    <ul class="SideBox_list list-stacked list-stacked--small list-stacked--2">
                                        <div id="article-access-count-loader" class="placeholder" data-replace="true" data-placeholder="/placeholder/v1/article/access-count/10.1186/1471-2407-10-401 #accessCount-container"></div>
                                        <div id="citation-count-loader" class="placeholder" data-replace="true" data-placeholder="/placeholder/v1/article/citation-count/10.1186/1471-2407-10-401 #count-container"></div>
                                        <div id="altmetric-loader" class="placeholder" data-replace="true" data-placeholder="/placeholder/v1/article/altmetric/10.1186/1471-2407-10-401 #altmetric-container"></div>
                                    </ul>
                                </div>
                                
    <div id="sociaMediaShare" class="SideBox">
        <h3 class="SideBox_title">Share this article</h3>
        <ul id="shareButtons" class="share">
            <li class="share__item">
                <button id="shareOnTwitter" class="js-btnShareOnTwitter share__button share__button--twitter" data-track-event="click"
                        data-event-category="Article Page" data-event-action="Share Twitter" data-event-label="10.1186/1471-2407-10-401">
                    <span class="sr-only">Share on Twitter</span>
                </button>
            </li>
            <li class="share__item">
                <button id="shareOnFacebook" class="js-btnShareOnFacebook share__button share__button--facebook" data-track-event="click"
                        data-event-category="Article Page" data-event-action="Share Facebook" data-event-label="10.1186/1471-2407-10-401">
                    <span class="sr-only">Share on Facebook</span>
                </button>
            </li>
            <li class="share__item">
                <button id="shareOnLinkedIn" class="js-btnShareOnLinkedIn share__button share__button--linkedin" data-track-event="click"
                        data-event-category="Article Page" data-event-action="Share LinkedIn" data-event-label="10.1186/1471-2407-10-401">
                    <span class="sr-only">Share on LinkedIn</span>
                </button>
            </li>
            <li class="share__item">
                <button id="shareOnWeibo" class="js-btnShareOnWeibo share__button share__button--weibo" data-track-event="click"
                        data-event-category="Article Page" data-event-action="Share Weibo" data-event-label="10.1186/1471-2407-10-401">
                    <span class="sr-only">Share on Weibo</span>
                </button>
            </li>
            <li class="share__item">
                <button id="shareOnGooglePlus" class="js-btnShareOnGplus share__button share__button--gplus" data-track-event="click"
                        data-event-category="Article Page" data-event-action="Share Google+" data-event-label="10.1186/1471-2407-10-401">
                    <span class="sr-only">Share on Google Plus</span>
                </button>
            </li>
            <li class="share__item">
                <button id="shareOnReddit" class="js-btnShareOnReddit share__button share__button--reddit" data-track-event="click"
                        data-event-category="Article Page" data-event-action="Share Reddit" data-event-label="10.1186/1471-2407-10-401">
                    <span class="sr-only">Share on Reddit</span>
                </button>
            </li>
        </ul>
    </div>

                                
    

                                
    
    <div id="articleSections" class="SideBox">
        <h3 class="SideBox_title">Section</h3>
    <ul class="list-stacked list-stacked--2 list-stacked--small">
        
        <li class="list-stacked__item">
            <a class="list-stacked__link" href="/articles/sections/genetics-genomics-and-epigenetics"
                   data-track-event="click"
                   data-event-category="Article Page"
                   data-event-action="Click section link"
                   data-event-label="10.1186/1471-2407-10-401">Genetics, genomics and epigenetics</a>
            </li>
    
        </ul>
    </div>
    

                                
    

                                <div class="SideBox">
                                    <h3 class="SideBox_title">Other Actions</h3>
                                    <ul class="list-stacked list-stacked--2 list-stacked--small">
                                        <li class="list-stacked__item">
                                            
    <a data-track-event="click" data-event-category="Article Page" data-event-action="Order article reprints" data-event-label="10.1186/1471-2407-10-401" href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=738&doi=10.1186%2F1471-2407-10-401&volume=10&issue=1&title=Combined+mutations+of+ASXL1%2C+CBL%2C+FLT3%2C+IDH1%2C+IDH2%2C+JAK2%2C+KRAS%2C+NPM1%2C+NRAS%2C+RUNX1%2C+TET2+and+WT1+genes+in+myelodysplastic+syndromes+and+acute+myeloid+leukemias&author_name=Julien+Rocquain&start_page=1&end_page=7">Order reprint</a>

                                        </li>
                                    </ul>
                                </div>
                                
        
        <div id="sociaMediaAccounts" class="SideBox">
            <h3 class="SideBox_title">Follow</h3>
            <ul class="follow follow--inline">
                
                <li class="follow__item">
                    <a class="follow__link follow__link--twitter-2" href="https://twitter.com/BMC_series" data-track-event="click" data-event-category="Social Media"
                       data-event-action="Click Follow Social Media" data-event-label="Twitter">
                        <span class="follow__label">Follow us on Twitter</span>
                    </a>
                </li>
                

                

                
            </ul>
        </div>
        
    
                            </aside>
                            
    <div id="FulltextAd" class="adsbox Ad Ad--skyscraper">
        <div class="Ad_content">
            <p class="Ad_label">Advertisement</p>
            <span id="pbgrd-43415139"></span>
        </div>
    </div>

                        </div>
                    </div>
                </div>
            </div>
        </main>
        
            <div class="journal-footer">
                <div class="journal-footer__inner">
                    <div class="journal-footer__summary">
                        <h4 class="journal-footer__title">
                            
                            <span class="journal-footer__title-text">BMC Cancer</span>
                        </h4>
                        <p class="journal-footer__issn">ISSN: 1471-2407</p>
                    </div>
                    
                        <div class="journal-footer__contact">
                            <h4 class="journal-footer__contact-title">Contact us</h4>
                            <ul class="journal-footer__contact-list">
                                
                                    <li class="journal-footer__contact-item">Editorial email: <a href="mailto:bmccancer@biomedcentral.com">bmccancer@biomedcentral.com</a></li>
                                
                                
                                    <li class="journal-footer__contact-item">Support email: <a href="mailto:info@biomedcentral.com">info@biomedcentral.com</a></li>
                                
                            </ul>
                        </div>
                    
                </div>
            </div>
        
         
    <footer>
        <div class="footer">
            <div class="footer__header">
                <img srcset="/static/images/biomed-central-logo-white-3c6c941205.svg" src="/static/images/biomed-central-logo-white-faac4202d5.png" class="logo__img footer__logo" alt="Biomed Central" />
                
                    <h2 class="footer__menu-title">Publisher Main Menu</h2>
                    <ul class="footer__primary-menu">
                        
                            <li class="footer__primary-item">
                                <a class="footer__link footer__primary-link" href="//www.biomedcentral.com/journals">Explore journals</a>
                            </li>
                        
                            <li class="footer__primary-item">
                                <a class="footer__link footer__primary-link" href="//www.biomedcentral.com/getpublished">Get published</a>
                            </li>
                        
                            <li class="footer__primary-item">
                                <a class="footer__link footer__primary-link" href="//www.biomedcentral.com/about">About BioMed Central</a>
                            </li>
                        
                    </ul>
                
            </div>
            <div id="Test-FooterExists" class="footer__content">
                <div class="footer__legal">
                    
                    <p class="footer__terms">By continuing to use this website, you agree to our <a class="footer__link footer__link--inline" href="//www.biomedcentral.com/terms-and-conditions">Terms and Conditions</a>, <a class="footer__link footer__link--inline"
                                                                                                                                                                                                                               href="//www.biomedcentral.com/terms-and-conditions/privacy-statement">Privacy
                        statement</a> and <a class="footer__link footer__link--inline" href="//www.biomedcentral.com/cookies">Cookies</a> policy.</p>
                </div>
                
    <nav id="publisherFooter" class="footer__nav">
        <h3 class="footer__menu-title">Publisher secondary menu</h3>
        <div class="footer__nav-inner">
            
            <div class="footer__menu">
                <ul class="footer__list">
                    
                    <li class="footer__item">
                        <a class="footer__link" href="http://blogs.biomedcentral.com/">Read more on our blogs</a>
                        
                    </li>
                    
                    <li class="footer__item">
                        <a class="footer__link" href="//www.biomedcentral.com/login">Receive BMC newsletters</a>
                        
                    </li>
                    
                    <li class="footer__item">
                        <a class="footer__link" href="//www.biomedcentral.com/account">Manage article alerts</a>
                        
                    </li>
                    
                    <li class="footer__item">
                        <a class="footer__link" href="http://authorservices.springernature.com/language-editing/">Language editing for authors</a>
                        
                    </li>
                    
                    <li class="footer__item">
                        <a class="footer__link" href="http://authorservices.springernature.com/scientific-editing/">Scientific editing for authors</a>
                        
                    </li>
                    
                </ul>
            </div>
            
            <div class="footer__menu">
                <ul class="footer__list">
                    
                    <li class="footer__item">
                        <a class="footer__link" href="//www.biomedcentral.com/about/policies">Policies</a>
                        
                    </li>
                    
                    <li class="footer__item">
                        <a class="footer__link" href="//www.biomedcentral.com/accessibility">Accessibility</a>
                        
                    </li>
                    
                    <li class="footer__item">
                        <a class="footer__link" href="//www.biomedcentral.com/about/press-centre">Press center</a>
                        
                    </li>
                    
                </ul>
            </div>
            
            <div class="footer__menu">
                <ul class="footer__list">
                    
                    <li class="footer__item">
                        <a class="footer__link" href="//www.biomedcentral.com/about/contact-us">Contact us</a>
                        
                    </li>
                    
                    <li class="footer__item">
                        <a class="footer__link" href="https://biomedcentral.typeform.com/to/VLXboo">Leave feedback</a>
                        
                    </li>
                    
                    <li class="footer__item">
                        <a class="footer__link" href="//www.biomedcentral.com/about/jobs">Careers</a>
                        
                    </li>
                    
                </ul>
            </div>
            
            <div class="footer__menu footer__menu--follow">
                <div class="footer__follow">
                    <h3 class="footer__follow-title">Follow BioMed Central</h3>
                    <ul class="follow follow--inline">
                    
                        <li class="footer__follow-item follow__item">
                            <a class="follow__link follow__link--twitter" href="https://twitter.com/biomedcentral" target="_blank" data-track-event="click" data-event-category="Social Media" data-event-action="Click Follow Social Media" data-event-label="Twitter">
                                <span class="follow__label">Twitter</span>
                            </a>
                        </li>
                    
                        <li class="footer__follow-item follow__item">
                            <a class="follow__link follow__link--facebook" href="https://www.facebook.com/BioMedCentral" target="_blank" data-track-event="click" data-event-category="Social Media" data-event-action="Click Follow Social Media" data-event-label="Facebook">
                                <span class="follow__label">Facebook</span>
                            </a>
                        </li>
                    
                        <li class="footer__follow-item follow__item">
                            <a class="follow__link follow__link--gplus" href="https://plus.google.com/106226337984152901734/" target="_blank" data-track-event="click" data-event-category="Social Media" data-event-action="Click Follow Social Media" data-event-label="Google Plus">
                                <span class="follow__label">Google Plus</span>
                            </a>
                        </li>
                    
                        <li class="footer__follow-item follow__item">
                            <a class="follow__link follow__link--weibo" href="http://www.weibo.com/biomedcentral" target="_blank" data-track-event="click" data-event-category="Social Media" data-event-action="Click Follow Social Media" data-event-label="Weibo">
                                <span class="follow__label">Weibo</span>
                            </a>
                        </li>
                    
                    </ul>
                </div>
            </div>
        </div>
    </nav>


            </div>
        </div>
        <div class="branding-bar">
            <div class="logo branding-bar__logo">
                <img srcset="/static/images/logo-springernature-4230d19d5c.svg" src="/static/images/logo-springernature-828f4f84c8.png" class="logo__img branding-bar-logo__img" alt="Springer Nature Logo" />
            </div>
            <p class="branding-bar__copyright">&#169; 2017 BioMed Central Ltd unless otherwise stated. Part of <a class="branding-bar__link" href="http://www.springernature.com">Springer Nature</a>.</p>
        </div>
    </footer>
    <noscript class="js-cookie-banner-noscript">
        <div class="cookie-banner js-cookie-banner">
            <div class="cookie-banner__inner">
                <p class="cookie-banner__message">
                    We use cookies to improve your experience with our site.
                    <a href="https://www.biomedcentral.com/cookies"
                       class="cookie-banner__link"
                       data-track-event="click"
                       data-event-category="EU Cookie Law Banner"
                       data-event-action="Find out more">More information <span class="sr-only">about our cookie policy</span>
                    </a>
                </p>
                <button hidden class="cookie-banner__dismiss js-cookie-banner-dismiss"
                        data-track-event="click"
                        data-event-category="EU Cookie Law Banner"
                        data-event-action="Close"><span class="cookie-banner__dismiss-text">Close</span>
                </button>
            </div>
        </div>
</noscript>


    </div>
    
    <img class='tracker' style='display:none' src='/track/article/10.1186/1471-2407-10-401' alt=""/>

    <div id="JFulltext"></div>

    
    <script type="text/javascript" src="//cdn.pbgrd.com/bmc.js" async="async"></script>

    

    
<script>
(function() {
    var linkEl = document.querySelector('.js-ctm');
    if (linkEl && window.matchMedia && window.matchMedia(linkEl.media)) {
        var vendorScript = document.createElement('script');
        vendorScript.src = '/static/js/oscar-vendor-67103b4f35.js';
        vendorScript.async = false;
        document.body.appendChild(vendorScript);
        var appScript = document.createElement('script');
        appScript.src = '/static/js/oscar-app-4e91ea0ef9.js';
        appScript.async = false;
        document.body.appendChild(appScript);
    }
})();
</script>



<script type="text/javascript">
    if (config) {
        (function (d) {
            Array.prototype.forEach.call(d.getElementsByClassName('RealMediaAd'), function (adElement) {
                var iframe = d.createElement('iframe');
                iframe.frameBorder = '0';
                iframe.scrolling = 'no';
                var position = adElement.getAttribute("data-position"),
                        iframeInDoc = adElement.getElementsByClassName('Ad_content')[0].appendChild(iframe),
                        doc = iframeInDoc.contentWindow.document;

                doc.open().write('<body onload="window.location.href = '
                        + '\'/placeholder/v1/advertising/realMedia?siteWithPath=' + encodeURIComponent(config.siteWithPath)
                        + '&placement=' + position + '\';">');
                doc.close();
            });
        })(document);
    }
</script>



    
        <script type="text/javascript">
            document.addEventListener('readystatechange', function () {
                if (document.readyState === 'complete') {
                    setTimeout(function () {
                        var script = document.createElement("script");
                        script.type = "text/javascript";
                        script.src = "https://recommendations.springernature.com/latest/entry-point.js";
                        document.getElementsByTagName("head")[0].appendChild(script);
                    }, 0);
                }
            });
        </script>
    


    <script type="text/javascript">
        var _kiq = _kiq || [];
        (function () {
            setTimeout(function () {
                var d = document, f = d.getElementsByTagName('script')[0], s = d.createElement('script');
                s.type = 'text/javascript';
                s.async = true;
                s.src = '//s3.amazonaws.com/ki.js/47412/9CC.js';
                f.parentNode.insertBefore(s, f);
            }, 1);
            setTimeout(function () {
                var d = document, f = d.getElementsByTagName('script')[0], s = d.createElement('script');
                s.type = 'text/javascript';
                s.async = true;
                s.src = '//s3.amazonaws.com/ki.js/47412/aC6.js';
                f.parentNode.insertBefore(s, f);
            }, 1);
        })();
    </script>


<noscript>
	<img hidden src="https://verify.nature.com/verify/nature.png" border="0" width="0" height="0" style="display: none">
</noscript>
</body>
</html>

